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Abstract 
Efferocytosis is the clearance of apoptotic cells and is necessary for homeostasis. Mer 
Tyrosine Kinase (MerTK) is a crucial efferocytic receptor whose loss is associated with 
chronic inflammatory diseases and autoimmunity. While previous studies have shown that 
MerTK mediates efferocytosis through a unique mechanism that requires integrins, MerTK 
signalling pathway remains unknown. Given this unusual internalization mechanism, I 
hypothesized that MerTK signals and engages integrins through a novel signalling pathway 
different from that used by other phagocytic receptors. Therefore, this study aimed to identify 
the signalling pathways activated by MerTK, utilizing conventional cell biology and 
pharmacological approaches.  
I found that M0 and M2, but not M1 primary human macrophages, expressed MerTK. 
Moreover, crosslinking MerTK induced endocytosis in a MerTK-dependent manner, which 
was independent of the common regulators of phagocytosis. Furthermore, crosslinking 
MerTK resulted in intracellular tyrosine phosphorylation partially dependent on Syk/Src-
family kinases and PI3-kinase, which denote their importance in MerTK tyrosine 
phosphorylation.  
 
 
 
 
Keywords: 
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Chapter 1: Introduction 
Efferocytosis is the engulfment of apoptotic cells by phagocytes and is necessary for the 
maintenance of homeostasis. Apoptotic cells present “eat-me” signals on their cell 
membrane which act as ligands to enable their recognition by phagocytic receptors. 
These receptors mediate the uptake and degradation of apoptotic cells in an anti-
inflammatory and non-immunogenic fashion. If efferocytosis is defective, apoptotic cells 
remain uncleared and eventually undergo secondary necrosis. This releases pro-
inflammatory intracellular contents and self-antigens into the surrounding tissues, and 
suppresses the secretion of anti-inflammatory cytokines, thereby promoting inflammation 
and autoimmunity 
1
. MerTK plays an important role in efficient efferocytosis and is 
required for prevention of the damaging effects of incomplete efferocytosis. Indeed, 
studies of MerTK mutants and genome-wide association studies have shown MerTK to 
be critical in the prevention of chronic inflammatory diseases such as atherosclerosis and 
autoimmune disorders such as lupus 
2,3
.  
 Apoptosis signalling pathway 1.1
Apoptosis is defined as programmed cell death that occurs as a normal part of 
development and homeostasis of cell population 
4
. There are two main pathways of 
apoptosis: the extrinsic pathway which is triggered by pro-apoptotic ligands (example, 
first apoptosis signal ligand,) binding onto death receptors (example, first apoptosis 
signal), and the intrinsic pathway, which induces apoptosis in response to noxious 
cellular stimuli generated by free radicals or lack of growth factors. Both pathways 
activate cysteine-aspartic proteases (caspases) that play crucial role in apoptosis 
2
. 
Caspases are synthesized in inactive forms called pro-caspases in which their catalytic 
domains are inhibited by the adjacent pro-domains 
5,6
. Activation occurs when the pro-
domain of the caspase is cleaved, thus uninhibiting the proteolytic domain. Caspases can 
be divided into two classes: initiator and effector caspases. Initiator caspases (caspase-8, 
9, and 10) cleave and activate other caspases, while effector caspases (caspase-3, 6, and 
7) cleave other cellular effectors that mediate the cellular changes associated with 
apoptosis 
5
. These effectors are important in mediating the removal of apoptotic cells. For 
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example, caspase-3 targets caspase-activated DNase, which degrades DNA during 
apoptosis, allowing the nuclear components to be dispersed throughout the forming 
apoptotic bodies. Many other effector proteins are involved in the degradation and 
packaging of apoptotic cellular materials 
7,8
. The combined activity of these proteins 
produces the typical morphological hallmarks of apoptosis such as nuclear fragmentation, 
deliberate disassembly of subcellular organelles, re-distribution of plasma membrane 
lipids, and packaging of cellular contents into blebs. Apoptotic blebs are protrusions of 
plasma membrane that form by actin-myosin contraction of the cortical actin 
cytoskeleton. These blebs contain the degraded cytoplasmic materials and organelles 
produced during apoptosis, and pinch off from the apoptotic cell to form apoptotic bodies 
which can then be efferocytosed 
9,10
.  The small size of apoptotic bodies make them easy 
targets for phagocytes, being much easier for phagocytes to engulf than intact cells.  
 Recognition, engulfment, and processing of apoptotic 1.2
cells 
The identification and removal of apoptotic cells is a three-step process in which 
phagocytes are recruited to the site of apoptosis by “find-me” signals, engage and engulf 
the apoptotic cell through “eat-me” signals displayed on the apoptotic cell surface, and 
finally degrade the apoptotic cell. In the first step of this process, apoptotic cells release 
find-me signals which act as chemoattractants to recruit phagocytes. These find-me 
signals include ATP, UTP, fractalkine, lysophosphatidylcholine (LPC), and sphingosine-
1-phosphate 
11
. The mechanisms leading to the release of most of these find-me signals 
are not well understood, with the exception of LPC which is released from apoptotic cells 
by a caspase-8-dependent activation of phospholipase A2 (PLA2). PLA2 cleaves 
phosphatidylcholine to LPC then LPC binds to the G-protein-coupled receptor, G2A, 
found on phagocytes such as macrophages, thereby enabling macrophage recruitment to 
the vicinity of the apoptotic cell 
7,12
. ATP and UTP signals through purinergic G-protein-
coupled receptors such as P2Y2, but their mechanism of release from apoptotic cells 
remains unclear 
13
. Fractalkine is only released by a few subsets of apoptotic cells, 
typically being released from apoptotic immune cells, and signals through the CX3CR1 
chemokine receptor 
14
.  
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Binding and engulfment of apoptotic cells are mediated by binding of “eat-me” signals 
on the apoptotic cell to efferocytic receptors on the phagocyte. Among these eat-me 
signals are phosphatidylserine, calreticulin, oxidized lipids and DNA. In most healthy 
cells, phosphatidylserine is confined to the inner leaflet of plasma membrane 
9,15
. This 
plasma membrane asymmetry is lost during apoptosis through the activation of lipid 
scramblases, leading to the exposure of normally intracellular lipids on the surface of 
apoptotic cells. Phosphatidylserine exposure is insufficient for efferocytosis, as evidenced 
by the presence of phosphatidylserine on healthy T and B-cells and on platelets 
16,17
. 
Efferocytosis of these cells is impaired, in part, by the presence of “don’t-eat-me” signals 
such as CD31 and CD47, which are shed or otherwise downregulated during apoptosis 
11,16
. Moreover, the concordant recognition of multiple eat-me signals may provide 
sufficient pro-efferocytic signalling to overcome the inhibitory effect of these don’t-eat-
me receptors. While phosphatidylserine is the best understood eat-me signal, it is clear 
that other eat-me signals play an important role in efferocytosis. Characterization of the 
other eat-me signals is on-going, but it is established that calreticulin is transported from 
the endoplasmic reticulum to the plasma membrane following endoplasmic reticulum 
stress, likely via the canonical endoplasmic reticulum-golgi secretion pathway 
14,18
. 
Oxidized LDL are generated by apoptosis-induced oxidants, and are recognized by 
efferocytic receptors including CD36 and other scavenger receptors 
19
. Although 
controversial, there is some evidence that mitochondrial or nuclear DNA may be exposed 
on the cell surface where it then acts as an eat-me signal which engages CD91 receptor 
20
. 
Some efferocytic receptors directly bind to these eat-me signals while others require 
bridging molecules. For example, T-cell Immunoglobulin Mucin family, Brain-specific 
Angiogenesis Inhibitor-1 , and Stablin-2 receptors directly bind to phosphatidylserine on 
apoptotic cells 
21–23, while MerTK and αvβ3 integrin bind to phosphatidylserine through 
bridging molecules 
16
.  
After recognizing eat-me signals on apoptotic cells, the phagocyte internalizes the 
apoptotic cell through actin reorganization, leading to the apoptotic cells being 
internalized into a membrane-bound vacuole termed efferosome in which it is degraded. 
It is not fully established how this degradation is achieved, but evidence from our lab 
demonstrates that efferosome maturation progresses through the canonical Rab5-Rab7 
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maturation pathway, but then recruits novel trafficking regulators at the lysophagosomal 
stage which may act to direct apoptotic-cell derived antigens away from MHC loading 
compartments. These experiments demonstrated that many of the regulators and vesicle 
fusion events that regulate the processing of phagocytic and endocytic cargos are required 
for the degradation of apoptotic cells (example, Rab5, Rab7, lysosomal fusion; reviewed 
in 
24
). We also found that unique proteins were recruited to the maturing efferosomes, 
perhaps accounting for the lack of antigen presentation and inflammation following 
efferocytosis (unpublished data, work by Y. Kim). 
 General characteristics of MerTK 1.3
1.3.1 MerTK structure and signalling 
MerTK is a receptor tyrosine kinase consisting of an extracellular domain with two 
immunoglobulin-like domains and two fibronectin III motifs, a transmembrane domain, 
and an intracellular kinase domain 
25
. It shares these features with Tyro-3 and Axl 
receptors making it part of the TAM (Tyro-3, Axl, Mer) subfamily 
26
. MerTK is 
expressed in cells of myeloid, epithelial, and reproductive origin. In the myeloid lineage, 
it is expressed in macrophages, dendritic cells, and platelets 
27
. Furthermore, 
overexpression of MerTK has been associated with oncogenic transformation in human 
malignancies such as colon, esophageal, and lung cancers 
28
.  
MerTK is required for normal clearance of apoptotic cells, as shown by Sather, et al. 
25
 
where soluble MerTK inhibited clearance of apoptotic cells. It is common for membrane-
bound receptors to generate a soluble form through proteolytic cleavage of the 
extracellular domain by metalloproteinase 
25
. This proteolytic cleavage of receptor 
tyrosine kinases generally functions to limit signalling through the receptor by 
eliminating the receptor’s ligand-binding capabilities, thus contributing to homeostasis 
through maintaining normal levels of the receptor tyrosine kinases 
25
. However, this 
cleavage can also impair receptor-mediated processes if excessive cleavage occurs. The 
study by Sather et al. 
25
 revealed that the extracellular domain of MerTK was cleaved by 
the metalloproteinase, TNF-α Converting Enzyme (TACE), resulting in a soluble form of 
MerTK. This cleavage was induced in vitro after treatment of the cells with phorbol 
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myristate acetate and lipopolysaccharide (LPS). The shed extracellular domain of MerTK 
then acted as a decoy receptor by binding to and sequestering Growth Arrest Specific-6 
(Gas-6). Sequestering Gas-6 was sufficient to impair MerTK activation, and thus impede 
macrophage engulfment of apoptotic cells 
25
. This was confirmed by addition of TNF-α 
Processing Inhibitor-0, a TACE inhibitor, which blocked MerTK shedding and restored 
normal efferocytosis. 
1.3.2 MerTK opsonins 
The importance of opsonins to MerTK function was first identified in platelets. MerTK 
ligation induces platelet degranulation and aggregation, thus mice lacking MerTK have 
platelet dysfunctions 
29
. Investigations into the natural ligand that induced MerTK-
dependent platelet aggregation led to the discovery that MerTK was not directly binding 
phosphatidylserine on activated platelets but was interacting via the opsonin, Gas-6. Later 
studies showed that MerTK not only engaged degranulating platelets, but also apoptotic 
cells, and revealed several other opsonins, such as Protein S, Tubby, and Tubby-Like 
Protein 1 (Tulp1), which could mediate the interaction between MerTK and apoptotic 
cells. Gas-6 and Protein S are gamma-carboxylated in a vitamin K-dependent manner, 
and act to bridge phosphatidylserine on apoptotic cells through their N-terminal Gla 
domain to MerTK through their C-terminal laminin G-like 
30
. Tubby and Tulp1 are 
phosphatidylinositide-binding intracellular transcription factors that are secreted through 
a non-canonical secretion pathway in the extracellular milieu 
31
, and facilitate Retinal 
Pigment Epithelial (RPE) cells efferocytosis. Caberoy et al. 
31
 demonstrated that Tubby 
and Tulp1 induce efferocytosis through activating MerTK. Tubby and Tulp1 bind to 
PI(4,5)P2 on apoptotic cells through their C-terminal Polyphosphate Binding Domain and 
to MerTK through their N-terminal Muramyl Dipeptide region 
31
. The binding of MerTK 
to opsonins on apoptotic cells results in clustering of MerTK, leading to 
autophosphorylation of MerTK kinase domain and thus activation of MerTK signalling 
and internalization of the apoptotic cells 
32,33
. 
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1.3.3 Discovery of MerTK as an efferocytic receptor 
The function of MerTK was first discovered in the RPE phagocytic model of congenital 
blindness. The RPE is a monolayer of cells crucial for proper functioning of the retina. 
Aside from providing a protective layer over top of the photosensitive layer of the eye, 
RPE cells also clear the eye of apoptotic debris – in particular the continually shed outer 
segments of photoreceptor cells 
34
. This shedding prevents buildup of toxic oxidative 
products within the photosensitive cells of the eye through an apoptosis-like process in 
which the oldest portion of the cell (the outer segment disc) is shed, displays eat-me 
signals, and is then phagocytosed by an adjacent RPE cell 
34
. The RPE model was used to 
define the overall process of efferocytosis: recognition, binding/engulfment, and 
degradation of the apoptotic target 
34
. MerTK was revealed to be central to RPE 
phagocytosis in these studies. Specifically, researchers studied the causative agent of 
retinal dystrophy in the Royal College of Surgeon (RCS) rat model (a rat model of 
recessively inherited retinal degeneration) 
34,35
. They found that in these rats, shed 
photoreceptor rod outer segments were bound by RPE cells but not internalized, leading 
to a histologically observable accumulation of outer segment debris. D’Cruz et al. 35 used 
positional cloning to identify the retinal dystrophy loci and discovered that this loci 
contained a mutation in the MerTK gene. An identical phenotype was observed when 
MerTK was knocked out in mice, confirming the role of the receptor in the RPE model 
36
. 
This phenotype is recapitulated in humans carrying similar recessive mutations in the 
MerTK loci 
37
. This demonstrates that MerTK is an essential receptor in clearance of 
shed photoreceptor outer segment in the retina, with mutation in MerTK being 
responsible for some cases of human juvenile retinal dystrophy 
35
.  
1.3.4 MerTK in autoimmunity and inflammation 
In addition to its role in maintaining vision through the removal of apoptotic outer rod 
segments, MerTK plays a broader role in maintaining homeostasis. It is established that 
when there is a defect in clearance of apoptotic cells, apoptotic cells are left uncleared. 
Over time these cells lose metabolic capacity, eventually degrading and undergoing 
secondary necrosis 
14
. These uncleared apoptotic cells release intracellular components, 
some of which are pro-inflammatory, into the extracellular space. These cellular 
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components, termed alarmins or danger signals, activate immune cells and induce 
inflammation 
38
. Combined with the release of self-proteins, the release of these alarmins 
may contribute to induction of autoimmunity 
38
.  
Systemic Lupus Erythematous (SLE) is a chronic autoimmune disease closely tied to 
failures in efferocytosis. SLE patients express a wide range of clinical manifestations 
affecting multiple systems such as the nervous, respiratory, cardiovascular, and renal 
system. A key clinical feature of SLE is the presence of anti-nuclear antibodies in patient 
sera, likely produced in response to the release of DNA and histones during secondary 
necrosis 
7,39
. Cohen et al. 
3
 reported that mice lacking the intracellular kinase domain of 
MerTK show delayed clearance of exogenously administered apoptotic cells in vivo. The 
mice developed serological manifestation of lupus including autoantibodies to ssDNA, 
dsDNA, and IgG, and production of rheumatoid factor. This study also observed that 
since the extracellular portion of MerTK was still intact, apoptotic cells were being bound 
but not internalized indicating that physical clearance from the intracellular space was the 
key step in preventing this lupus-like autoimmunity. Therefore, accumulation of 
apoptotic cell is a stimulus for systemic autoimmune disease 
3
. Furthermore, Recarte-Pelz 
et al. 
40
 examined the genetic profiles and plasma concentrations of Gas-6, Protein S, and 
soluble forms of TAM receptors in SLE patients. They discovered increased soluble form 
of Gas-6 and TAM receptors in the SLE patients but decreased soluble form of Protein S, 
suggesting that opsonin availability and differences in opsonin activity may correlate 
with disease onset or activity in SLE 
40
. 
In addition to preventing autoimmunity, MerTK also plays a role in preventing chronic 
inflammatory diseases such as atherosclerosis. Atherosclerosis is a cardiovascular disease 
characterized by hardening and thickening of the artery due to plaque formation 
41
. There 
is evidence that impaired efferocytosis of dying cells is linked to progression of 
atherosclerosis 
2,42
. The pathophysiology of atherosclerosis begins with infiltration of 
macrophages and immune cells into the tunica intima of an artery in response to the 
deposition of Low-Density Lipoprotein (LDL) and the subsequent release of 
apolipoprotein B-100 in the intima 
41
. Macrophages are recruited to these sites, where 
they internalize the cholesterol-rich LDL (a process that produces severe cell stress), 
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leading the macrophages to differentiate into foam cells and eventually become apoptotic. 
These foam cells are not cleared via efferocytosis, leading to an accumulation of 
secondary necrotic debris in the core of the lesion 
2,43
. As the lesion matures it loses 
stability, eventually rupturing and producing an intravascular thrombus. If this thrombus 
detach, it can lodge in smaller vessels within the heart or brain producing a myocardial 
infarct or ischemic stroke, respectively 
44
.  
A key feature of the atherosclerotic environment is the accelerated apoptosis of 
macrophages and smooth muscle cells along with defective removal of the dying cells, 
leading to an accumulation of necrotic cells 
41
. This accumulation of necrotic cells 
appears to be due to defective or impaired efferocytosis, as indicated in a study by Thorp 
et al. 
43
. In this study, kinase-defective MerTK/ApoE
-/-
 mice macrophages were unable to 
clear cholesterol-induced apoptotic macrophages in vitro, which suggest that MerTK 
plays an important role in efferocytosis in atheroma. Moreover, Ait-Oufella et al. 
42
 
examined the role of MerTK in atherosclerosis by irradiating and reconstituting 
atherosclerotic-susceptible mice with MerTK
-/-
 or MerTK
+/+
 bone marrow. After the mice 
were subjected to high fat diet, MerTK
-/-
 mice had apoptotic cell accumulation within 
atherosclerotic lesion, accelerated lesion development, and a stronger pro-inflammatory 
immune response. This suggests that MerTK is important for bone marrow-derived cell 
efferocytosis and control of inflammation 
42
.  
Human studies have linked MerTK with atherosclerosis for instance, the study by 
Hurtado et al. 
45
 provided a link between Gas-6 and carotid atherosclerosis. Analysis of 
the genetic link between Single-Nucleotide Polymorphisms (SNPs) and haplotypes in 
Gas-6-TAM genes and carotid atherosclerosis led to discovery that SNPs in Tyro3 and 
MerTK were associated with carotid atherosclerosis, which highlights a role of the Gas-
6-TAM pathway in atherosclerosis. When Hurtado et al. 
46
 studied mRNA and protein 
expression of Gas-6, Protein S, and TAM receptors in human atherosclerotic carotid 
arteries, they noticed increased MerTK and Protein S in the atherosclerotic arteries versus 
normal arteries. While the source of the MerTK and Protein S was unclear, the expression 
profile of these genes in healthy individuals would suggest that they are most likely 
expressed on cells of a myeloid origin example, macrophages infiltrating the lesion site. 
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The previously mentioned studies demonstrating that MerTK function to reduce 
cellularity in atherosclerotic plaques suggest that this increased expression of MerTK and 
Protein S in the atheroma may act to reduce the overall severity of the disease. Together, 
these studies provide unequivocal evidence of the importance of MerTK and 
efferocytosis in atherosclerosis. 
 Fcγ receptor signal transduction as a putative model of 1.4
MerTK signalling 
While little is known of the signalling of efferocytic receptors such as MerTK, it is likely 
that they share some commonalities with other internalization pathways. Indeed, 
phagocytic receptors face many of the same challenges as efferocytic receptors, such as 
engagement and internalization of large particulate targets, and therefore represent good 
models of putative efferocytic signalling pathways. Fcγ receptors (FcγR) are among the 
best understood phagocytic receptors. These receptors recognize the Fc region of IgG-
class antibodies, allowing for phagocytosis of antibody-opsonised pathogens 
47
. Three 
classes of Fcγ receptors have been identified: FcγRI, FcγRII, FcγRIII, with each class 
having multiple isoforms. For instance, FcγRI is a high affinity receptor that can bind to 
monomeric IgG, it is encoded by three genes (FcγRIA, FcγRIB, and FcγRIC), and is 
expressed in monocytes and macrophages 
48. FcγRII is also encoded by three genes 
(FcγRIIA, FcγRIIB, and FcγRIIC) but is a low affinity receptor. Like FcγRII, FcγRIII is a 
low affinity receptor but is encoded by two genes (FcγRIIIA and FcγRIIIB) 48. Not all 
Fcγ receptors are pro-phagocytic, with some such as FcγRIIB binding to IgG but 
inhibiting particle internalization 
49
. While vastly different in structure and affinity, these 
receptors share a common signalling pathway, with the FcγRI, FcγRIIA, and FcγRIIIA 
mediating phagocytosis through Immunoreceptor Tyrosine-based Activation Motifs 
(ITAM), and the inhibitory FcγRIIB negatively regulating this ITAM pathway via 
Immunoreceptor Tyrosine-based Inhibition Motifs (ITIM) 
48
.  
Phagocytosis by FcγRs is initiated by binding of antibody-coated particle by these 
receptors, leading to clustering of the receptors. Signalling is initiated by phosphorylation 
of two tyrosine residues in the ITAM motifs by members of the Src-family of kinases. 
Phosphorylation of ITAMs provides binding sites for the SH2-containing kinase, Syk, 
10 
 
 
 
which then mediates downstream signalling 
16
 (Figure 1). This pathway is central to 
FcγR-mediated phagocytosis as indicated by severe phagocytic deficits in Syk-/- mice, 
which are completely unable to internalize IgG-opsonised particles 
50
.  
Phosphorylation and activation of Syk leads to recruitment of additional signalling 
adaptor proteins to the FcγR complex. The transmembrane protein Linker of Activated T-
cell (LAT) directly binds to activated Syk and its phosphorylation induces recruitment of 
other adaptor proteins such as Grb2 and Gab2 to the complex 
16
. Gab2 activates the lipid 
kinase, Phosphoinositide 3-Kinase (PI3K). CrkII, an adaptor protein, and Syk activates 
the guanine nucleotide exchange factor, DOCK180, and Vav, respectively, which in turn 
activates Rac1 (a small guanosine triphosphatase phosphatase) which enables actin 
remodeling 
16
 (Figure 1). Lipids play an important role in FcγR-mediated phagocytosis. 
PI3K quickly accumulates at the site of phagocytic cup and phosphorylates PI(4,5)P2 
producing PI(3,4,5)P3 which accumulates in the phagocytic cup 
16
 (Figure 1). PI(3,4,5)P3 
is required for macrophages to engulf large particles (greater than 3μm in diameter), but 
is dispensable for the uptake of smaller particles 
24,51
. Importantly, the inhibitory Fcγ 
receptor, FcγRIIB, functions by recruiting Src homology 2 domain-containing protein 
tyrosine phosphatase to its ITIM domain. Intermixing of the inhibitory receptor with 
engaged activating receptor delivers this ITIM-recruited phosphatase which then 
antagonizes signalling through the activating receptor’s ITAM motifs by 
dephosphorylating both the ITAMs and the Src-family kinases which act to 
phosphorylate the ITAMs 
16. This ITAM/FcγR signalling pathway appears to be utilized 
by other phagocytic receptors 
52,53
, suggesting it may be a universal pathway used by all 
receptors involved in large particle ingestion, making it an intriguing model for 
elucidating the signalling of other phagocytosis-like receptors such as MerTK-mediated 
efferocytosis. 
Another important model of phagocytosis of relevance to the study of MerTK is the 
integrin-mediated phagocytosis model. Integrins are heterodimeric, transmembrane 
receptors comprising of an alpha and beta subunit 
54,55
. They regulate cell signalling, cell 
cycle and shape, cell migration, and phagocytosis 
56,57
. Integrins act as receptors in both 
phagocytosis and efferocytosis, although the signalling of these receptors has only been  
11 
 
 
 
 
 
 
 
 
 
 
Figure 1: Core FcγR phagocytic signalling pathways. 
The signalling pathway involves binding of the ligand-coated particle onto Fcγ receptor, 
clustering of the receptors, leading to transmission of downstream signals, and particle 
internalization by actin-driven process. The dashed arrow indicates indirect activation.  
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explored in models of phagocytosis. Importantly to my thesis, the integrins αvβ3 and αvβ5 
are likely involved in MerTK-mediated uptake of apoptotic cells, suggesting that MerTK 
signalling must intercept the integrin-phagocytic pathway at some point 
58,59
.  
Integrins can signal in two directions: inside-out signalling and outside-in signalling. 
Inside-out signalling induces the high affinity state of integrins, and is driven by 
intracellular signalling. Integrins in their inactive state are in a bent conformation that 
masks their binding domain, creating a low affinity for their ligands. Inside-out signalling 
occurs when the N-terminal domain of the cytoskeletal protein, talin, binds to the NPX 
(Y/F) motif in β tail of the integrin, changing its conformation such that the binding site 
is exposed leading to an increase in its affinity for its ligands 
60
. In addition, inside-out 
signalling can increase the diffusion of integrins, allowing for integrin clustering, leading 
to a concurrent increase in integrin avidity, and further enhancing integrin-ligand 
interactions 
60
. Outside-in signalling occurs when the high-affinity integrin binds to its 
ligand. Ligand binding to the extracellular domains of an active integrin recruits a 
network of proteins, leading to local reorganization of actin cytoskeleton. Regulators of 
the outside-in signalling pathways include focal adhesion kinase (FAK), Rho GTP-
binding proteins, and adaptor proteins such as Cas, Crk, and paxillin 
60
. Both the outside-
in and inside-out signalling pathways are required for integrin-mediated phagocytosis and 
may be equally important for MerTK-mediated efferocytosis. 
Complement receptor 3, also known as Mac-1 or αmβ2, was the first phagocytic integrin to 
be characterized 
16,60. Phagocytosis by αmβ2 requires external stimulatory signals such as 
chemokines or bacterial products to activate Rap1 (a member of the Ras family of small 
GTP-binding proteins). This leads to recruitment of talin to the β tail of αmβ2 leading to 
its activation. Bacteria opsonised with complement C3bi binds to αmβ2 leading to 
internalization of the bacteria by RhoA-dependent actin polymerization pathway 
16,60
. 
Following ligation of αmβ2, RhoA is activated and recruited to the site of phagocytosis 
where it activates the serine/threonine kinase, Rho-associated protein kinase (ROCK), 
which then mediates recruitment of actin-related protein-2/3 and activation of myosin IIA 
to drive actin polymerization and reorganization. There is evidence that mutation of the 
β-integrin intracellular tail impedes RhoA activation and thus phagocytosis 56. In 
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addition, αmβ2 appears to be able to activate the Src/Syk pathway utilized by Fcγ 
receptors via the ITAM-bearing adaptor proteins, FcRγ and DAP12 61. This suggests that 
a combination of ITAM signalling and RhoA is important for αmβ2- mediated 
phagocytosis and therefore may be important for efferocytosis via the MerTK-integrin 
pathway.  
The integrins identified as being involved in clearance of apoptotic cells are not the same 
as those involved in phagocytosis. Efferocytic integrins include αvβ3 and αvβ5 
53,59
. Like 
MerTK, αvβ5 does not directly bind to phosphatidylserine on apoptotic cells but instead is 
bridged by the opsonin, Milk Fat Globule-EGF factor 8 (MFG-E8), also known as 
lactadherin (Figure 2). While αmβ2-mediated phagocytosis is dependent on RhoA, it is 
unclear if RhoA plays a role in αvβ5 efferocytosis. Moreover, it has not been tested 
whether the ITAM/Src/Syk pathway is utilized by any efferocytoic receptor. It is 
established that αvβ5 efferocytosis is dependent on Rac1 activation 
60
, which occurs 
downstream of ITAMs during FcγR-dependent phagocytosis. αvβ5 activates Rac1 by the 
Dock180-ELMO complex (a cascade that involves p130Cas and CrkII pathway) and the 
RhoA-related protein, RhoG, all processes thought to be downstream of Src-family 
kinases and/or ITAMs 
26,58
. Critically, Wu et al. 
58
 revealed that neither MerTK nor αvβ5 
integrin are independently sufficient for efferocytosis, but instead that efferocytosis 
requires their combined activity. We believe this indicates that MerTK provides the 
inside-out signal that induces the high affinity state of αvβ5, which then engages the 
apoptotic cell and recruits the full internalization machinery to the forming efferocytic 
cup through its outside-in signalling (Figure 2) – a possibility to be tested in our future 
studies. 
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Figure 2: Schematic of the known αvβ5 integrin and MerTK signalling pathway. 
MerTK signalling pathway may intersect with αvβ5 integrin through activation of FAK by 
Src-family kinases mediating the internalization of apoptotic cells. 
 
 
 
 
 
 
 
 
 
 
 
16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 Hypothesis and objectives 1.5
The signalling pathway of MerTK in macrophages remains unknown, but because 
efferocytosis results in a vastly different immunological outcome compared to 
phagocytosis, I hypothesized that MerTK signals and engages integrins through a 
novel signalling pathway different from that used by other phagocytic receptors. To 
address this hypothesis, my initial objectives were to determine if common regulators of 
phagocytosis/endocytosis regulate MerTK-mediated efferocytosis, and to use 
phosphotyrosine immunoprecipitation followed by mass spectrometry to identify kinase 
pathways activated by MerTK ligation. Once the proteins were identified and validated, 
their signalling dynamics were to be assessed by confocal microscopy of fluorescently-
tagged signalling molecules and through siRNA/pharmacological inhibition. Initially, I 
also proposed to generate tagged and mutagenized variants of MerTK to use in the 
signalling and immunoprecipitation studies. Lastly, I had planned on comparing the 
activity of the identified signalling pathways under normal and atherosclerotic conditions 
thereby identify any defects in MerTK signalling that may account for its role in 
atherosclerosis. 
However, due to difficulties in identifying a cell line with consistent MerTK expression 
and in generating an ectopic expression model, the project proposal had to be modified. 
Instead, in my first objective I characterized the expression of endogenous MerTK in 
primary human macrophages. In my second objective, MerTK endocytosis was induced 
in M0 primary human macrophages by antibody-crosslinking, and the role of the 
common phagocytic regulators Src-family kinases, Syk and PI3K in MerTK endocytosis 
were assessed using pharmacological inhibitors. Thirdly, the role of these signalling 
pathways was assessed in the induction of MerTK-dependent tyrosine phosphorylation. 
In the final objective, I sought to immunoprecipitate proteins tyrosine-phosphorylated by 
MerTK crosslinking, with the goal of identifying these signalling regulators using an 
unbiased mass spectrometry approach. 
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Chapter 2: Materials and methods 
 Murine macrophage cell culture 2.1
RAW264.7 and J774.1 murine macrophages were cultured in RPMI-1640 (Wisent) 
containing 10% Fetal Bovine Serum (Invitrogen). ANA-1 murine macrophages were 
cultured in Dulbecco's Modiﬁed Eagle's Medium (Wisent) supplemented with 10% FBS. 
All cells were cultured at 37°C in 5% CO2 and split at 80% confluency. RAW264.7 and 
J774.1 cells were a gift from S. Grinstein, Hospital for Sick Children, and ANA-1 cells 
were a gift from M. Valvano, Western University.  
 Primary human macrophage cell culture 2.2
Blood collection was approved by Western University’s Health Sciences Research Ethic 
Board and complies with the Tri-Council Policy Statement on human research. Human 
blood was drawn from healthy consenting donors using butterfly blood collection needles 
and 10mL BD Vacutainer sodium heparin tubes (Thermo Fisher). Blood was layered in 
15mL Falcon tubes over an equal volume of Lympholyte-poly cell separation media 
(Cedarlane), followed by centrifugation at 500 x g for 35 minutes with no brake, and 
removal of the top band of cells, the peripheral blood mononuclear cells (PBMCs). 
PBMCs were washed with room-temperature phosphate-buffered saline (PBS) at 300 x g 
for 6 minutes, diluted with RPMI-1640 containing 10% FBS and antibiotic antimycotic 
solution (Corning), then plated on 12-well plates with 18mm coverslips placed in the 
wells or on 6-well plates coated with 0.1% gelatin solution. Cells were incubated at 37°C 
under 5% CO2 for 1 hour to allow selective adherence of the PBMCs.  
After 1 hour, cells were washed with warm PBS to remove non-adherent cells followed 
by addition of RPMI-1640 containing 10% FBS, antibiotic antimycotic solution (100X), 
and differentiated with cytokines (1000X) from R&D Systems: 10ng/mL recombinant 
human (rh) M-CSF (to obtain M0 & M2) or 20ng/mL rhGM-CSF (to obtain M1), 
differentiation for 5 days, followed by an additional 2 days of culture with 10ng/mL rhM-
CSF (for M0), 20ng/mL rhGM-CSF + 250μg/mL LPS + 100ng/mL IFN-γ (for M1) or 
10ng/mL rhM-CSF + 10μg/mL IL-4 (for M2).   
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 Cloning human MerTK-wild type, mouse MerTK-wild 2.3
type and GFP, and human HA-MerTK 
Human and mouse MerTK cDNA was purchased from the MGC genome collection. PCR 
was used to amplify MerTK using Phusion High-Fidelity DNA Polymerase (Thermo 
Scientific) with 35 cycles. Amplification primers were designed with SnapGene software 
and are listed in Table 1 and 2. PCR products were purified using EZNA Cycle Pure Kit 
(Omega Biotek). The amplified PCR products and target vectors were digested with their 
corresponding restriction enzymes (Fermentas), as shown in Table 1 and 2, for 2 hours at 
37ºC, purified using Geneclean II EZ-Glassmilk Kit (MP Biomedicals), and then ligated 
overnight at 16°C using T4 DNA ligase (Fermentas). DNA sequencing was performed by 
the London Genomics Centre (Robarts Research Institute, London, Canada). Plasmid 
maps are located in the appendix (Figure A1).  
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Table 1: Primers for cloning human MerTK-WT, mouse MerTK-WT, and mouse 
MerTK-GFP 
Insert 
name 
Amplification primer sequence (5’ to 3’) 
with restriction sites underlined  
Restriction 
Enzyme 
Target 
vector 
Human 
MerTK-
WT 
FWD: AAA AAA GAA TTC ATG GGG 
CCG GCC C 
REV: AAA AAA ACC GGT TCA CAT 
CAG GAC TTC TGA GCC TTC T 
EcoRI 
 
AgeI 
 
pEGFP-
N1 
Mouse 
MerTK-
WT 
FWD: AAA AAA GAA TTC ATG GTT 
CTG GCC CCA CTG 
REV: AAA AAA ACC GGT TCA CAT 
CAG AAC TTC AGA GTC TTC CAA GG 
EcoRI 
 
AgeI 
 
pEGFP-
N1 
Mouse 
MerTK-
GFP 
FWD: TAT GAA TTC ATG GTT CTG GCC 
CCA CTG CTA CTG 
REV: GGT GGC GAC CGG TTT CAT 
CAG AAC TTC AGA GTC TTC CA AGG 
AGT 
EcoRI 
 
AgeI 
 
pEGFP-
N1 
 
 
 
 
 
 
22 
 
 
 
Table 2: Primers for cloning human HA-MerTK 
Insert name Amplification primer sequence (5’ to 
3’) with restriction sites underlined  
Restriction 
Enzyme 
Target 
vector 
Upstream 
half of HA-
MerTK 
FWD: TTT TTT AGA TCT GCT ATC 
ACT GAG GCA AGG GAA GAA 
REV: GAA GAG GGG GCA TAG 
TCG ACC CAA CCG TGT GCA GGG 
ATA AAT 
BglII 
 
SalI 
 
pDisplay-
LAP2 
Downstream 
half of HA-
MerTK 
FWD: ATT TAT CCC TGC ACA 
CGG TTG GGT CGA CTA TGC CCC 
CTC TTC 
REV: TTT TTT CTC GAG TCA CAT 
CAG GAC TTC TGA GCC TTC TGA 
SalI 
 
XhoI 
 
pBluescript 
Full-length 
HA-MerTK 
FWD: TTT TTT AGA TCT GCT ATC 
ACT GAG GCA AGG GAA GAA 
REV: TTT TTT CTC GAG TCA CAT 
CAG GAC TTC TGA GCC TTC TGA 
BglII 
 
XhoI 
 
pDisplay-
LAP2 
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Table 3: Antibodies with dilutions and sources 
Antibody Dilution Source 
Rabbit monoclonal anti-
mouse MerTK antibody 
1:1000 Abcam 
Donkey anti-rabbit IR-700 1:10,000 Jackson ImmunoResearch 
Rabbit monoclonal anti-
human MerTK 
1:1000, 1:500, 1:200 Abcam 
Dylight 488-conjugated 
Fab fragment donkey anti-
rabbit IgG 
1:1000 Jackson ImmunoResearch 
Cy3-conjugated Fab 
fragment donkey anti-
rabbit IgG 
1:1000 Jackson ImmunoResearch 
Goat anti-human 488 Fab 1:1000 Jackson ImunoResearch 
F(ab’)2 goat anti-rabbit 
IgG Fc fragment specific  
1:200 Jackson ImmunoResearch 
Dylight 488-conjugated 
Fab anti-mouse  
1:1000 Jackson ImmunoResearch 
Goat anti-rabbit Cy3-
conjugated F(ab’)2 
1:500 Jackson ImmunoResearch 
Mouse monoclonal anti-
phosphotyrosine, clone 
4G10 
1:1000 Millipore 
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 Immunoblotting for endogenous MerTK on RAW264.7 2.4
and J774.1 cells 
RAW264.7 and J774.1 cells were plated at approximately 5 x 10
5 
cells per 35mm-
diameter well and were incubated for 24 hours to obtain approximately 80% confluency. 
Cells were lysed with 4X Laemmli buffer containing 1/10
th 
volume of β-mercaptoethanol, 
and protease plus phosphatase inhibitors (100X, Thermo Scientific). Cell lysates were 
vortexed for 30 seconds, boiled at 100°C for 5 minutes, and ran on a 12% SDS-PAGE for 
one hour at 110V. Protein bands were transferred onto a nitrocellulose membrane for two 
hours at 85V, then membrane was blocked with Tris-Buffered Saline with Tween (TBST) 
plus 5% Bovine Serum Albumin (BSA) for 4 hours. The membrane was probed with 
rabbit monoclonal anti-mouse MerTK antibody (1:1000, Abcam) for 2 hours and donkey 
anti-rabbit IR-700 (1:10,000, Jackson ImmunoResearch) for 1 hour. Three-15 minutes 
washes with TBST followed each antibody incubation step. The membrane was imaged 
with LI-COR Odyssey Infrared Imaging System.  
 Immunostaining for MerTK expression 2.5
J774.1 and ANA-1 macrophages were plated at approximately 5 x 10
5 
cells per 18mm 
coverslip on a 12-well plate and were incubated for 24 hours to obtain approximately 
80% confluency, while primary human macrophages were cultured onto 12-well plates 
with coverslip as per “Primary human macrophage cell culture” protocol (Section 2.2). 
Cells were fixed with 4% PFA at room temperature for 20 minutes then blocked with 1% 
BSA at room temperature for 30 minutes. Primary human macrophages were 
immuostained with DAPI (1:1000, Abnova) and rabbit monoclonal anti-human MerTK 
(1:1000, Abcam) while J774.1 and ANA-1 macrophages were stained with DAPI and 
rabbit monoclonal anti-mouse MerTK for 1 hour, followed by Dylight 488-conjugated 
Fab fragment donkey anti-rabbit IgG (1:1000, Jackson ImmunoResearch) and Cy3-
conjugated Fab fragment donkey anti-rabbit IgG (1:1000, Jackson ImmunoResearch), 
respectively. Cells were mounted with PermaFluor and images were acquired using 
Olympus IX70 inverted fluorescent microscope equipped with a 60X/0.9NA objective 
and operated by micro-manager software 
63
, or imaged on a Zeiss LSM510 meta confocal 
microscope equipped with a 60X/1.0NA objective.  
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 Co-transfection of HeLa and RAW264.7 cells with 2.6
pIRES2-EGFP MerTK and mCherry-Rab7 
Cells were seeded onto 18mm coverslips placed into the wells of a 12-well plate and 
incubated for 24 hours at 37°C to obtain approximately 80% confluency. The media on 
the cells was replaced with fresh media one hour prior to transfection. RAW and HeLa 
cells were transfected with 1.1μg of each plasmid using FuGENE-HD transfection 
reagent (Promega). After 24 hours of transfection, the cells were fixed with 4% PFA and 
mounted with PermaFluor (Thermo Scientific). The pIRES2-EGFP murine MerTK 
plasmid was purchased from Addgene (#14998). Plasmid map is located in the appendix 
(Figure A1). Images were captured using Olympus IX70 inverted fluorescent microscope 
equipped with a 60X/0.9NA objective and operated by micro-manager software 
63
. 
 Phagocytosis assay of M0 primary human 2.7
macrophages 
M0 primary human macrophages were cultured onto a 12-well plate as per “Primary 
human macrophage cell culture” protocol (Section 2.2). 4.95μm Protein A-coated beads 
and 5.09μm polystyrene microsphere beads (Bangs Laboratories) were used as 
phagocytic targets.  
Protein A-coated beads were prepared by diluting 10μL of beads with 500μL of 1X PBS. 
For anti-human MerTK-coated beads, 10μL of the diluted beads was mixed with 2.5μL of 
rabbit monoclonal anti-human MerTK antibody. For isotype control beads, 10μL of the 
diluted beads was mixed with 2.5μL of whole human IgG. Beads were rotated for 30 
minutes at room temperature, washed with 1mL of 1X PBS, and stained with eFluor 670 
Cell Proliferation Dye (1:1000, eBioscience). Beads were washed, re-suspended with 
1mL of HEPES RPMI, and added into each well of macrophages. Macrophages were 
centrifuged at 500 x g for 1 minute then phagocytosis was induced by incubating them at 
37ºC for 30 minutes. After incubation, cells were washed with 1X PBS then non-
internalized beads were labelled with anti-rabbit 488 Fab, or goat anti-human 488 Fab 
(Jackson ImmunoResearch) for isotype control. Cells were fixed with 4% PFA for 20 
minutes at room temperature, immunostained for MerTK and counterstained with DAPI 
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as per immunostaining protocol (Section 2.5). After mounting with Permaflour (Thermo 
Scientific), images were acquired with 60X objective using Olympus IX70 inverted 
fluorescent microscope.  
Polystyrene microsphere beads were prepared by mixing 10μL of the beads with 500μL 
of PBS, and 2.5μL of F(ab’)2 goat anti-rabbit IgG Fc fragment specific antibody (Jackson 
ImmunoResearch) then rotating for 15 minutes at room temperature. Beads were washed 
three times with 1X PBS and blocked with 500μL of 5% BSA for 15 minutes, washed 
thrice again, and then 10μL of beads were re-suspended with 500μL of 1X PBS and 
rabbit monoclonal anti-human MerTK antibody (1:200, Abcam) or rabbit anti-sheep Far 
Red for the isotype control. Beads were rotated for 1 hour then washed thrice. Anti-
human MerTK beads were labelled with eFluor 670 Cell Proliferation Dye (1:1000, 
eBioscience). Beads were re-suspended with 1mL of HEPES RPMI. Phagocytosis was 
induced by adding the 1mL of bead-containing HEPES RPMI into each well of 
macrophages, centrifuging at 500 x g for 1 minute, and incubating plates at 37°C for 30 
minutes. Unbound beads were removed by three washes with 1X PBS then non-
internalized external beads were labelled with Dylight 488-conjugated Fab fragment 
donkey anti-rabbit IgG (1:1000, Jackson ImmunoResearch) for 20 minutes. Cells were 
washed, fixed with 4% PFA for 20 minutes at room temperature, and mounted with 
Permaflour. Images were acquired with 60X objective using DIC and Olympus IX70 
inverted fluorescent microscope.  
 Induction of IgG-mediated phagocytosis by RAW264.7 2.8
cells 
RAW264.7 macrophages were plated at approximately 5 x 10
5 
cells per 18mm coverslip 
on a 12-well plate and were incubated for 24 hours to obtain approximately 80% 
confluency. Whole mouse IgG-coated beads were prepared by mixing 10μL of 5.09μm 
polystyrene microsphere beads (Bangs Laboratories) with 300μL of 1X PBS and 15μL 
whole mouse IgG then rotating for 1 hour at room temperature. Beads were washed twice 
and re-suspended with 500μL of 1X PBS then 10μL of coated beads was added to each 
well of macrophages in 1mL of serum-free HEPES RPMI. The cells were centrifuged at 
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500 x g for 1 minute then incubated at 37°C for 30 minutes. Unbound beads were 
removed by two washes with room temperature 1X PBS and non-internalized external 
beads labelled with anti-mouse Dylight 488 antibody (1:1000; Jackson ImmunoResearch) 
for 20 minutes. Cells were washed twice, fixed with 4% PFA for 20 minutes at room 
temperature, and mounted with Permaflour. For inhibition of IgG-mediated phagocytosis, 
the cells were treated with 50μM LY294002, 50μM piceatannol, and 30μM PP1 for the 
duration of the experiment. Images were acquired with 60X objective using DIC and 
Olympus IX70 inverted fluorescent microscope. Phagocytic index was calculated by 
dividing the total number of internalized beads by total number of macrophages counted. 
A minimum of 45 macrophages were counted for each condition (untreated, LY294002, 
piceatannol, and PP1-treated) in one experiment. Images were analyzed on Fiji ImageJ 
software (http://fiji.sc/Fiji). Graph was created using GraphPad Prism. 
 MerTK endocytosis assay 2.9
M0 primary human macrophages were cultured onto 18mm coverslips on a 12-well plate 
as per “Primary human macrophage cell culture” protocol (Section 2.2). Basal levels of 
endocytosis was inhibited by pre-incubating cells for 4 hours prior to the experiment in 
serum-free RPMI-1640, and the cells were cooled to 10°C prior to MerTK crosslinking. 
MerTK was ligated by the addition of rabbit anti-human MerTK (1:500, Abcam) for 20 
minutes at 10°C, followed by three washes in 1X PBS, and then crosslinked with goat 
anti-rabbit Cy3-tagged F(ab’)2 (1:500, Jackson ImmunoReaserch). The cells were washed 
with 37°C RPMI with HEPES and incubated at 37°C for 20 minutes to allow for MerTK 
internalization. Internalization was stopped by washing the cells with 10°C 1X PBS, and 
surface-bound antibody was removed by 2 minutes acid-wash (1X PBS, pH 2.0 10°C). 
Cells were fixed for 20 minutes with 4% PFA at 10°C, co-stained with wheat-germ 
agglutinin (1:1000) for 5 minutes at 10°C, and then mounted with Permaflour (Thermo 
Scientific). A sufficient number of fields (4-5 fields, 10 cells/field) were imaged before 
and after acid washing to ensure a statistically representative sample of MerTK 
expression and internalization. Images were acquired using Olympus IX70 inverted 
fluorescent microscope equipped with a 60X/0.9NA objective and operated by micro-
manager software 
63
.  
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For pharmacological inhibition studies, macrophages were incubated with the PI3K 
inhibitor LY294002 at 50μM, the Syk inhibitor piceatannol at 50μM, and the Src-family 
kinase inhibitor PP1 (Tocris Bioscience) at 30μM from 10 minutes prior to internalization 
until fixation. 
 Phosphotyrosine immunostaining 2.10
M0 primary human macrophages were cultured as per “Primary human macrophage cell 
culture” protocol (Section 2.2). Cells were serum starved for 4 hours to reduce basal 
phosphoprotein levels then cooled at 10°C for 15 minutes. For pharmacological 
inhibition studies, macrophages were incubated with the PI3K inhibitor LY294002 at 
50μM, the Syk inhibitor piceatannol at 50μM, and the Src-family kinase inhibitor PP1 at 
30μM, with inhibitors added 20 minutes prior to stimulation and kept on the sample until 
fixation. Rabbit monoclonal anti-human MerTK (1:500, Abcam) was added to the cells 
for 20 minutes at 4°C, the cells were washed three times with 4°C 1X PBS then treated 
with crosslinking goat anti-rabbit Cy3-tagged F(ab’)2 (1:500, Jackson ImmunoResearch). 
Cells were incubated at 4°C for 20 minutes then fixed with 4% PFA for 20 minutes at 
room temperature. Cells were blocked and permeabilized with 1X PBS + 0.1% Triton X-
100 + 5% rat serum for 1 hour at room temperature followed by incubation with mouse 
monoclonal anti-phosphotyrosine antibody, clone 4G10 (1:1000, Millipore) in blocking 
buffer overnight at 4°C. Cells were immunostained with donkey anti-mouse 488-tagged 
Fab secondary antibody (1:1000, Jackson ImmunoResearch) for 1 hour at room 
temperature. Images were acquired using Olympus IX70 inverted fluorescent microscope 
equipped with a 60X/0.9NA objective and operated by micro-manager software 
63
.  
 Phosphotyrosine immunoblotting 2.11
ANA-1 macrophages were plated onto 35mm-diameter well and incubated for 24 hours 
to obtain approximately 80% confluency. Cells were serum starved with serum-free 
DMEM for 4 hours under 37°C, 5% CO2 incubation. 10μL of Protein G beads (Pierce) 
was washed once with 1X PBS, suspended in 100μL of 1X PBS, and then 3μL of rabbit 
monoclonal anti-mouse MerTK or 10μL of whole mouse IgG for isotype control was 
added to the beads. Beads were rotated for 30 minutes at room temperature, washed twice 
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with 1X PBS, and re-suspended in 3mL of 10°C serum-free DMEM. After 4 hours of 
serum-starvation, the cells were cooled with 10°C serum-free DMEM for 15 minutes then 
2mL of 10°C bead media was added to the cells. Cells were spun at 300 x g for 1 minute 
at 10°C and incubated at 10°C for 20 minutes. Cells were lysed with 4X Laemmeli buffer 
containing 1/10
th 
volume of β-mercaptoethanol and protease and phosphatase inhibitors 
(100X), vortexed for 30 seconds, boiled at 100°C for 5 minutes, and ran on 12% SDS-
PAGE. Protein bands were transferred to a nitrocellulose membrane and membrane was 
blocked with TBST plus 5% BSA for 4 hours. The membrane was probed with mouse 
monoclonal anti-phosphotyrosine antibody, clone 4G10 (1:1000; Millipore) for 2 hours 
and anti-mouse IR-700 (1:10,000) for 1 hour. Three-15 minutes washes with TBST 
followed each antibody incubation step. The membrane was imaged with LI-COR 
Odyssey Infrared Imaging System.   
M0 primary human macrophages were cultured on 6-well plates with coverslips 
following “Primary human macrophage cell culture” protocol. The cells were serum-
starved with serum-free RPMI for 4 hours prior to the experiment. Unstimulated cells 
were left on ice in serum-free HEPES RPMI while EGTA-treated cells were treated with 
PEG media (0.045g of sucrose, 0.019g of 5mM EGTA, and 10μL of 1X PBS) for 10 
minutes on ice. To stimulate cells with IgG immune complex, whole human IgG was 
heated at 62°C for 20 minutes, spun at 16,000 x g for 10 minutes, and then the 
supernatant was added to the cells (1:40 dilution in HEPES RPMI). The cells were 
incubated at 37°C for 30 minutes and washed with ice-cold 1X PBS. MerTK was 
activated by treating the cells with 1:1000 rabbit monoclonal anti-human MerTK 
antibody (Abcam) for 20 minutes on ice, then crosslinking with goat anti-rabbit Cy3-
tagged F(ab’)2 (1:1000, Jackson ImmunoResearch) for 20 minutes on ice. Cells were 
incubated on ice for an additional 20 minutes to enhance tyrosine phosphorylation then 
lysed with 4X Laemmeli buffer containing 1/10
th 
volume of β-mercaptoethanol and 
protease and phosphatase inhibitors (100X). Cell lysate was ran on 12% SDS-PAGE and 
transferred to nitrocellulose membrane. The membrane was blocked with 5% BSA for 4 
hours, probed with mouse monoclonal anti-phosphotyrosine antibody, clone 4G10 
(1:1000; Millipore) for 2 hours and anti-mouse IR-700 (1:10,000, Jackson 
ImmunoResearch) for 1 hour. For loading control, the membrane was probed with mouse 
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anti-actin antibody (1:500, Developmental Studies Hybridoma Bank) and anti-mouse IR-
800. Three-15 minutes washes with TBST followed each antibody incubation step. The 
membrane was imaged with LI-COR Odyssey Infrared Imaging System.  
 Phosphotyrosine immunoprecipitation 2.12
M0 primary macrophages were cultured on a one-well plate coated with 0.1% gelatin as 
per “Primary human macrophage cell culture” protocol (Section 2.2). Cells were serum-
starved with serum-free RPMI for 4 hours prior to the experiment. Unstimulated cells 
were left on ice in serum-free HEPES RPMI while MerTK activated cells were treated 
with rabbit monoclonal anti-human MerTK at a dilution of 1:500 for 20 minutes on ice 
followed by goat anti-rabbit Cy3-tagged F(ab’)2 secondary antibody (1:500) for 20 
minutes on ice. Cells were incubated for additional 20 minutes then lysed with 1mL of 
lysis buffer containing wash buffer (20mM Tris-HCl pH 8.0, 0.15M NaCl, 2mM EDTA, 
1% Nonidet P-40, 10% glycerol, 1mM Na3VO4), 0.25mM phenylmethylsulfonyl fluoride, 
200nM Okadaic acid, 10mM NaF, and protease and phosphatase inhibitor (100X). The 
cell lysate was rotated at 4°C for 40 minutes then spun at maximum speed for 15 minutes. 
The supernatant was recovered and 50μL was kept for lysate controls while 40μL of anti-
phosphotyrosine antibody, clone 4G10, agarose conjugate (EMD Millpore) was added to 
the remainder of the supernatant. The supernatant was incubated at 4°C rotating for 16 
hours.  
After the 16-hours incubation, the slurry was washed five times with wash buffer 
followed by elution with 70μL of 1X phenyl phosphate, disodium salt dehydrate (Fisher 
Scientific) at 4°C for 30 minutes. The slurry was spun at 4°C at maximum speed for 15 
minutes and the immunoprecipitate recovered. A one-quarter volume of 4X Laemmli 
buffer with 50mM DTT was added to the immunoprecipitate and 0.5% total cell lysate 
samples, which were then boiled for 2 minutes at 100°C, and ran on a 10% SDS-PAGE at 
100V for 2 hours. The gel was fixed with 40% ethanol + 10% acetic acid for 15 minutes, 
and stained with BioRad QC colloidal coomassie stain for 20 hours. The gel was 
destained with deionized water for 3 hours then imaged on Gel Doc EZ Imager from 
BioRad. 
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 Quantification of mean fluorescence intensity and co-2.13
localization 
Mean Fluorescence Intensity (MFI) was measured by tracing the area occupied by cells 
on Fiji ImageJ software while taking background measurement for each cell. Twenty 
cells per condition for each experiment were analyzed. Corrected means were calculated 
on Microsoft Excel spreadsheet by subtracting the means from the background 
measurements, then MFI graph was created using GraphPad Prism software. 
Pearson’s correlation coefficient was calculated on Fiji ImageJ software using Just 
Another Co-localization Plugin 
64
. Thresholds values were set for 4G10 and MerTK 
images. R values calculated by the plugin were imported into Microsoft Excel 
spreadsheet which was used to calculate average R values for each group in each 
experiment. Calculation of standard error of the mean (SEM), graphs and statistics were 
then created using GraphPad Prism software.  
 Statistical analysis 2.14
One-tailed Student’s t-tests or ANOVA using Bonferroni method were performed as 
appropriate using GraphPad Prism software. Data are presented as mean + SEM. 
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Chapter 3: Results 
 Murine macrophage cell lines lack consistent MerTK 3.1
expression 
Cell lines consistently expressing endogenous MerTK were required for my research. 
Therefore, I quantified MerTK expression using western blotting of the commonly used 
murine macrophage cell lines, RAW647.2 (RAW) and J774.1 
65–67
. The first western blot 
did not show protein band corresponding to MerTK for RAW cells but, consistent with 
reports in the literature 
68
, showed a faint band between 100-150 kDa corresponding to 
MerTK for J774.1 cells as indicated by the red arrow (Figure 3A). The same culture of 
cells displayed a plasmalamellar (ring-like) distribution of MerTK on J774.1 cell surface 
by confocal microscopy (Figure 3B), consistent with the J774.1 cell line expressing 
MerTK. However, it was not possible to consistently reproduce these results in J774.1 
cells. Subsequent immunoblots either lacked any protein bands or displayed only non-
specific antibody binding to proteins of the incorrect molecular mass, while subsequent 
microscopy experiments observed a small percentage (less than 5%) of J774.1 cells 
showing a weak plasmalamellar staining pattern with the bulk of the cells in the samples 
showing no staining (data not shown). Several alternate primary antibodies and cell 
culture conditions were tested, but none of these produced consistent and clear MerTK 
expression, thereby eliminating J774.1 cells as a viable model system. 
The less commonly used ANA-1 murine macrophage cell line was then tested for 
endogenous MerTK expression. Both conventional immunofluorescence images (Figure 
3C) and confocal microscope images (Figure 3D) revealed non-specific background 
fluorescence instead of the expected plasmalamellar staining indicative of MerTK 
expression. Since microscopy has limited sensitivity, I indirectly tested for MerTK 
expression by adding MerTK antibody-conjugated beads, followed by phosphotyrosine 
immunoblotting to detect any resulting MerTK signalling. This method was used because 
it has been shown that receptor activation leads to phosphorylation of downstream 
proteins detectable by immunoblotting 
19
. The resulting immunoblot revealed only basal  
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A) Western blotting performed on RAW264.7 and J774.1 cell lysates revealed MerTK 
protein band only in J774.1 (red arrow). This blot represents the one experiment, out of 
five, which showed MerTK protein band. B) Fluorescent microscopy of endogenous 
MerTK expression on J774.1 macrophages using confocal microscopy. The image is 
representative of ten images captured in one experiment. Scale bar is 10 μm. C) 
Widefield microscopy image of ANA-1 macrophages immunostained with anti-mouse 
MerTK (red) and counterstained with DAPI (blue). Image is representative of three 
independent experiments. Scale bar is 10μm. D) Confocal Z-stack image of ANA-1 
macrophage stained with anti-mouse MerTK (red). Image is representative of three 
images captured in one experiment. E) Phosphotyrosine (4G10) immunoblot of either 
20μL or 40μL of ANA-1 cell lysates from non-crosslinked (Iso) or MerTK (Mer) 
crosslinked cells. The blot is representative of two experiments.  
 
 
 
 
 
 
Figure 3: Murine macrophage cell lines lack consistent MerTK expression.  
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levels of phosphorylation in the MerTK crosslinked lane (Figure 3E). The lack of 
increased phosphorylation in stimulated ANA-1 cells combined with the 
immunofluorescence results confirms that these cells do not express endogenous MerTK. 
Therefore, none of the tested murine macrophage cell lines were viable models for 
MerTK analysis.    
 Generating MerTK ectopic expression system 3.2
The lack of consistent MerTK expression on murine macrophage cell lines necessitated 
the generation of macrophages stably expressing ectopic MerTK. I tried several methods 
to clone full-length MerTK for instance, conventional cloning of wild-type human and 
murine MerTK, and murine GFP-tagged MerTK into the mammalian expression vector, 
pEGFP-N1 (Table 1, appendix Figure A1). However, screening for positive clones by 
restriction enzyme digestion revealed either empty vectors or inserts only a few hundred 
base-pairs in size (data not shown), rather than the expected 3 kb full-length MerTK 
amplicon produced by PCR.  
Since conventional cloning methods were unsuccessful, a different approach was carried 
out, as highlighted in Figure 4A, to generate HA-tagged human MerTK. A SalI site was 
inserted into the middle of MerTK by site-directed mutagenesis in fashion that does not 
introduce a change in the amino acid sequence (Figure 4A). A BglII site was inserted 
upstream of the gene and an XhoI site downstream (Table 2). The 5’ (BglII to SalI) 
fragment of MerTK was amplified by PCR and cloned into the HA-containing pDisplay-
LAP2 vector, while the 3’ fragment (SalI to XhoI) was to be cloned into pBluescript. 
Cloning of both fragments was determined to be successful by colony PCR and DNA 
sequencing (data not shown), after which the 3’ MerTK fragment was excised from 
pBluescript and ligated into the 5’ pDisplay-LAP2 vector digested with SalI and XhoI.  
The transformation of this construct led to recovery of only a small number of clones.  
Colony PCR of the resulting constructs revealed a 3 kb band believed to be full-length 
MerTK (red box, Figure 4B). However, when sequenced, only MerTK constructs 
containing point mutations, insertion and deletions, or frame-shift mutations were  
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A) SnapGene schematic of one of several strategies used to attempt cloning HA-tagged 
human MerTK into pDisplay-LAP2. B) Colony PCR gel of full-length MerTK cloned 
into pDisplay-LAP2. Colony 2 (red square) appears to be a full-length (3 kb) MerTK 
clone. C) Alignment comparing human MerTK with the sequence of colony 2 (C2) from 
panel B. Point mutations are highlighted in green, frame-shift mutation is highlighted in 
red, and a stop codon arising due to the frame-shift mutation is highlighted in cyan. 
 
 
 
 
 
 
 
 
Figure 4: Generating HA-tagged human MerTK ectopic expression system.  
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C) 
          830        840         850         860         870  
MerTK  AGTGCAGATCAACATCAAAGCAATTCCCTCCCC-ACCAACTGAAGTCAGCATCCGTAACA 
       :::::::::::::::::::::: : :::::::: :::::::::::::::::::::::::: 
C2     AGTGCAGATCAACATCAAAGCATTCCCCTCCCCCACCAACTGAAGTCAGCATCCGTAACA 
 
      880        890        900         910         920         930 
MerTK  GCACTGCACACAGCATTCTGATCTCCTGGGTTCCTGGTTTTGATGGATACTCCCCGTTCA 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
C2     GCACTGCACACAGCATTCTGATCTCCTGGGTTCCTGGTTTTGATGGATACTCCCCGTTCA 
 
 
 
 
 
 
 
3 kb 
MW   1   2   3   4   5 
Colony  
B) 
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recovered. An example of this is shown in Figure 4C, where the alignment of a recovered 
MerTK clone with the reference human MerTK sequence shows both point mutations and 
a frame-shift mutation (highlighted in green and red, respectively). The frame-shift 
mutation creates a premature stop codon within the reading frame (cyan highlight, Figure 
4C) producing a truncated protein lacking the transmembrane and intracellular kinase 
domains. The failure of our earlier cloning attempts and this sequencing result is 
consistent with this gene being somehow toxic to the bacteria used for cloning, perhaps 
due to low-level expression resulting in cytosolic expression and aggregate formation of a 
normally transmembrane protein. Thus, this toxicity would lead to recovery of only rare 
mutated sequences such as those illustrated in Figure 4C which eliminate the portions of 
the MerTK gene causing toxicity in the cloning bacteria.  
 pIRES2-EGFP murine MerTK is not expressed in 3.3
transfected HeLa and RAW264.7 cells 
During our attempts at cloning MerTK, a murine MerTK plasmid with MerTK under 
control of a mammalian promoter plus a downstream pIRES2-EGFP became available 
from Addgene (appendix Figure A1). I attempted to use this construct to make a stable 
MerTK expressing cell line that could then be used for studying MerTK signalling 
pathway. HeLa and RAW cells were co-transfected with this construct, plus a mCherry 
(example, mCherry-Rab7) expressing plasmid as a positive control for transfection. The 
images revealed high rates of transfection, as indicated by high levels of mCherry 
expression in a large proportion of both HeLa (>70% transfection) and RAW cells (>30% 
transfection, Figure 5, top images). However, the mCherry positive cells lacked GFP 
expression (Figure 5, bottom images), and thus lacked MerTK expression. Several 
different transfection ratios of MerTK:mCherry were tested with none producing 
measurable MerTK/GFP expression (data not shown). It is unclear why we did not 
observe MerTK/GFP expression in these cells, as sequencing of the plasmid revealed the 
expected sequence of MerTK and there were no signs of toxicity in the transfected cells.  
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HeLa and RAW264.7 cells were co-transfected with mCherry-Rab7 (top images) and 
pIRES2-EGFP murine MerTK plasmid (bottom images). Images were taken through 60X 
objective on an inverted fluorescence microscope and are representative of three separate 
experiments. Scale bar is 10 μm. 
 
 
 
 
 
 
 
 
Figure 5: pIRES2-EGFP murine MerTK is not expressed in transfected HeLa or 
RAW264.7 cells. 
42 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HeLa RAW246.7  
p
IR
E
S
2
-E
G
F
P
 
m
C
h
er
ry
- 
R
a
b
7
 
43 
 
 
 
 MerTK is expressed in M0 and M2 primary human 3.4
macrophages 
Since none of the tested murine cell lines expressed MerTK and our attempts at cloning 
and expressing recombinant MerTK had failed, I altered my approach in order to use 
primary human cells expressing endogenous MerTK. This required identification of a 
phagocytic cell type that expressed MerTK under normal conditions. Therefore, I tested 
primary human macrophages differentiated into M0 (unpolarized), M1, or M2 subtypes 
and analysed them for endogenous MerTK expression.  
M0 and M2 macrophages exhibited a pattern of MerTK expression characteristic of a 
plasma membrane localized protein, while M1 macrophages displayed mostly non-
specific background fluorescence (Figure 6A). Quantification of these images revealed 
that 88 percent of M0 macrophages were MerTK positive, 93 percent of M2 were MerTK 
positive, while only 18 percent of M1 were MerTK positive (Figure 6B). When MerTK 
expression levels were quantified, the small portion of MerTK positive M1 cells 
expressed significantly less MerTK than M0 or M2 cells, while M0 and M2 cells 
expressed equivalent amounts of MerTK (Figure 6C). This led to the conclusion that 
MerTK is expressed on primary human macrophages of the M0 and M2 lineages. I chose 
to use M0 macrophages for all subsequent experiments as these macrophages are the least 
differentiated and are capable of further differentiation, thereby increasing the likelihood 
that results observed in these macrophages will be consistent between multiple subtypes 
of macrophages and will provide the opportunity to assess the impact of MerTK 
signalling in mediating further macrophage differentiation. 
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A) M0, M1, and M2 macrophages were labelled with rabbit anti-human MerTK plus 
Dylight 488-tagged Fab (green) and DAPI (blue). Images were captured through 60X 
objective and are representative fields from two different experiments. Scale bar is 10 
μm. B) Percentage of MerTK positive cells. Asterisks indicate statistically significant 
difference (P < 0.05) compared with M1 macrophages using ANOVA with Bonferonni 
correction. C) MerTK expression levels in mean fluorescence intensity. n.s. indicates 
non-significant difference between M0 and M2, and asterisk indicates significant 
difference compared to both M0 and M2 using ANOVA with Bonferonni correction. 
Twenty cells per condition per experiment were analysed. Data are shown as mean + 
SEM.  
 
 
 
 
 
 
Figure 6: MerTK is expressed in M0 and M2 primary human macrophages. 
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 Measuring MerTK-dependent efferocytosis by M0 3.5
primary human macrophages 
After it was established that MerTK is expressed on M0 macrophages, MerTK’s 
efferocytic ability was assessed using antibody-coated beads that were expected to 
selectively engage MerTK, but not other efferocytic or phagocytic receptors. Different 
methods were used to generate these beads, with all methods aimed at masking the Fc 
region of the anti-MerTK antibody in order to avoid engagement of Fcγ receptors 
(methods used to produce the different beads is described in section 2.7). All of the 
various anti-MerTK-coated beads were readily internalized as indicated by the white 
arrows (Figures 7A left image; Figure 7B top panels).  
Unfortunately, in all cases, isotype antibody-coated beads (negative controls) were 
internalized equally well (Figures 7A right image; Figure 7B bottom panels, white 
arrows), indicating that our bead preparation methods were unable to mask the Fc region 
of the anti-MerTK antibody, thus leading to internalization at least partially by FcγR-
mediated phagocytosis. Therefore, MerTK-specific efferocytosis by M0 macrophages 
was not achieved, requiring that we improve the specificity of our bead model. This work 
is currently being pursued by other members of our laboratory. 
 Crosslinking MerTK on M0 primary human 3.6
macrophages induces endocytosis independent of 
Src/Syk and PI3-kinase 
It is well established that crosslinking of phagocytic receptors induces the same signalling 
and internalization pathways as do particulate targets engaging the same receptor 
69
. 
Since our bead-based efferocytic assays were non-specific, we took advantage of this 
phenomenon and used MerTK-crosslinking to selectively stimulate MerTK on M0 
primary human macrophages. MerTK was crosslinked through addition of the anti-
MerTK antibody which was then either crosslinked by the addition of a Cy3-labelled 
dimeric secondary F(ab’)2. Endocytosis was quantified by first imaging total MerTK on 
the cells using widefield fluorescence microscopy, followed by an acid-wash to dissociate 
antibodies from non-internalized MerTK, and then the cells were re-imaged to detect the  
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A) Efferocytosis analysis of anti-human MerTK-coated Protein A beads (left image) and 
whole human IgG (isotype control)-coated Protein A beads (right image). Images are 
representative of two experiments. B) Efferocytosis assay of polystyrene beads coated 
with anti-human MerTK then labelled with eFluor 670 (top images). Bottom images 
show isotype control beads. Cells were imaged through 60X objective using a widefield 
fluorescent microscope. Images are representative of ten images captured over three 
experiments. Scale bar is 10 μm. 
 
 
 
 
 
 
 
Figure 7: Measuring MerTK-dependent efferocytosis by M0 primary human 
macrophages. 
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residual (internalized) MerTK signal. Endocytosis was quantified as the amount of 
fluorescence after acid-washing (internalized MerTK) divided by the fluorescence before 
acid-washing (total MerTK). These efferocytosis assays were then used to investigate the 
role of Src-family kinases, Syk kinase, and PI3K (all critical regulators of other 
phagocytic receptors) in MerTK-mediated endocytosis. 
As a negative control, MerTK on M0 primary human macrophages was labelled but not 
crosslinked through the addition of an anti-MerTK antibody plus a monovalent Cy3-
labelled secondary Fab. Without crosslinking, MerTK showed the expected 
plasmalamellar distribution on the surface (Figure 8A, top panel). Acid-washing removed 
most of this MerTK labelling (Figure 8A, bottom panel, and Figure 8C), indicating that 
little basal endocytosis of MerTK occurred and that Fcγ receptors were not being 
significantly engaged. The cells were counterstained with Cy5-WGA to demarcate their 
plasma membrane.  
To stimulate MerTK on M0 macrophages, MerTK was activated through the addition of 
an anti-MerTK antibody followed by crosslinking with divalent secondary Cy3-
conjugated F(ab’)2. As shown in the top panel of Figure 8B, crosslinking induced a 
punctate distribution of MerTK reminiscent of endosomes. Acid-washing was unable to 
remove this staining, confirming that MerTK had been internalized into an endosome-like 
compartment (Figure 8B, bottom panel). Quantification of cells pre- versus post-acid 
wash determined that 76 ± 17% of MerTK was internalized (Figure 8D). 
Given that MerTK crosslinking was a viable model of MerTK internalization, I then 
addressed whether its endocytosis is dependent on PI3K, Syk or Src-family kinases by 
treating M0 primary human macrophages with inhibitors of those proteins. As before, 
non-crosslinked MerTK was not endocytosed (Figure 9A). When MerTK was 
crosslinked, endocytosis was detected even after acid-washing the cells (Figure 9B). 
Treatment of MerTK-crosslinked M0 macrophages with the PI3K inhibitor LY294002, 
the Syk inhibitor piceatannol, or the Src-family kinase inhibitor PP1, had no notable 
impact on MerTK endocytosis after crosslinking (Figure 9C-E). Quantification of both 
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MerTK endocytosis was quantified by measuring total MerTK by fluorescence 
microscopy, followed by removal of non-internalized MerTK staining with acid-washing 
and re-imaging of the samples. The plasma membrane was demarcated with Wheat Germ 
Agglutinin (WGA). A) Basal (non-crosslinked) endocytosis of MerTK. B) Endocytosis of 
crosslinked MerTK (F(ab’)2) on M0 macrophages C) Quantification of MerTK mean 
fluorescence intensity (MFI) of pre- versus post-acid washed, non-crosslinked condition. 
The asterisk indicates statistical significance by one-tailed Student’s t-test (P < 0.05). D) 
Quantification of MerTK MFI of pre- versus post-acid washed, MerTK-crosslinked cells. 
n.s indicates no statistically significant difference between non-acid washed and acid-
washed conditions; one-tailed Student’s t-test. Data are presented as mean + SEM. 
Images are representative of three independent experiments. Scale bar is 10 μm. 
 
 
 
 
 
Figure 8: Crosslinking MerTK on M0 primary human macrophages induces 
endocytosis. 
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MerTK mean fluorescence intensity (Figure 9F) and percent internalization (Figure 9G) 
confirmed these results. These results demonstrate that endocytosis of MerTK is 
independent of PI3K, Syk, and Src-family kinases. 
To confirm the effectiveness of the inhibitors, the ability of the inhibitors to block the 
well-established FcγR-mediated phagocytosis of IgG-coated beads was performed using 
RAW macrophages. RAW macrophages were fed unlabelled IgG-coated beads and after 
an internalization period, non-internalized beads were labelled with a Dylight 488-
conjugated secondary antibody (green). As expected, untreated cells readily 
phagocytosed the majority of beads (Figure 10A, 10E) and FcγR-mediated phagocytosis 
was considerably blocked by all three inhibitors, LY294002, piceatannol, and PP1 
(Figure 10B-D, 10E).
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MerTK endocytosis was quantified by measuring total MerTK by fluorescence 
microscopy, followed by removal of non-internalized MerTK staining with acid-washing 
and re-imaging of the samples. The plasma membrane is demarcated by WGA. A) 
Endocytosis of MerTK in unstimulated (Fab labelled) M0 macrophages. B) Endocytosis 
assay of untreated MerTK-crosslinked (F(ab’)2) M0 macrophages. C-E) Endocytosis 
assay of PI3K-inhibited (C, LY294002), Syk-inhibited (D, piceatannol), and Src-family 
kinase-inhibited (E, PP1) MerTK-crosslinked macrophages. F) MerTK MFI pre and post 
acid-washing on either untreated or inhibitor-treated M0 macrophages. G) Percent 
MerTK internalization based on the data from panel F. All images are taken through 60X 
objective. Scale bar is 10 μm. Data are presented as mean + SEM from three independent 
experiments. Differences among means are not statistically significant by ANOVA with 
Bonferroni correction.  
 
 
 
 
 
 
Figure 9: Endocytosis of MerTK is independent of Src/Syk-kinases and PI3K. 
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A) DIC and 488 channel (green) images of IgG-mediated phagocytosis on untreated 
RAW macrophages as positive control. B-D) DIC and 488 channel images of IgG-
mediated phagocytosis on B) PI3K, C) Syk, and D) Src-family kinase-inhibited 
RAW264.7 macrophages. E) Phagocytic index of untreated, PI3K-inhibited (LY294002), 
Syk-inhibited (piceatannol), and Src-family kinase-inhibited (PP1) RAW264.7 
macrophages; (n = 1). Scale bar is 10 μm.  
 
 
 
 
 
 
 
 
Figure 10: Inhibition of IgG-mediated 
phagocytosis. 
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 Tyrosine phosphorylation of MerTK on M0 primary 3.7
human macrophages is partially dependent on Src/Syk 
and PI3-kinase  
Previous studies have shown that activating phagocytic receptors by crosslinking will 
lead to phosphorylation of the downstream proteins which drive the internalization of the 
phagocytic targets 
69
. Our results revealed MerTK endocytosis follows crosslinking, so 
we investigated whether activating MerTK on M0 macrophages would also induce 
tyrosine phosphorylation like that observed downstream of classical phagocytic receptors. 
Phosphotyrosine (4G10) immunostaining of unstimulated M0 macrophages detected 
typical patterns and levels indicative of basal protein phosphorylation, with the 
phosphotyrosine immunostaining showing the punctuate staining typical of focal 
adhesions that account for a large portion of basal phosphorylation (Figure 11A). As a 
positive control we activated Fcγ receptors with aggregated IgG, which has been 
previously established to trigger a large increase in tyrosine phosphorylation 
69
, and 
observed the expected increase in numerous punctate phosphotyrosine structures on the 
cells consistent with aggregated IgG-activated Fcγ receptors (Figure 11B).  
When MerTK was labelled, but not crosslinked, through the addition of anti-MerTK plus 
a Cy3-conjugated Fab antibody, basal levels of phosphorylation were observed (Figure 
11C, top panel). Crosslinking MerTK with Cy3-conjugated F(ab’)2 appeared to increase 
total cellular tyrosine phosphorylation (Figure 11C, bottom panel). We noticed that 
enriched phosphotyrosine staining was only observed on cells with strong MerTK signal 
(white arrows), consistent with this increase in phosphorylation being due to MerTK 
crosslinking. To confirm these data, Pearson’s co-localization analysis of MerTK with 
phosphotyrosine (4G10) staining was performed. The Pearson’s R-value was greatly 
increased on MerTK crosslinked cells, indicating a strong co-localization of 
phosphoproteins with MerTK (Figure 11D). Despite this strong co-localization after 
crosslinking there was no statistically significant difference in the 4G10 mean 
fluorescence intensity between basal and MerTK-crosslinked condition, although the data 
trended towards increased phosphorylation (Figure 11E).  
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A) Unstimulated M0 macrophages expressing MerTK were immunostained for tyrosine-
phosphorylated proteins (4G10, green). B) M0 macrophages stimulated with aggregated 
human IgG were immunostained for tyrosine-phosphorylated proteins. C) MerTK on M0 
macrophages were either unstimulated (Fab, top panel) or crosslinked (F(ab’)2, bottom 
panel), then the cells were immunostained to detect tyrosine-phosphorylated proteins 
(4G10, green). D) Pearson’s correlation coefficient between immunostaining of MerTK 
and tyrosine-phosphorylated proteins (4G10) in images of unstimulated macrophages 
(Fab) and MerTK-crosslinked macrophages (F(ab’)2). The asterisk indicates P < 0.05 
compared with Fab by one-tailed Student’s t-test. Ten fields were analysed from four 
experiments. E) Fold change of tyrosine-phosphorylated protein expression of 
unstimulated (basal), aggregated human IgG (AgIgG), non-crosslinked MerTK (Fab), and 
crosslinked MerTK (F(ab’)2) cells. Results are representatives of four experiments (n = 4 
+ SEM). n.s. denotes no significant difference by ANOVA with Bonferroni correction. 
Scale bar is 10 μm. 
Figure 11: Co-localization of MerTK and tyrosine-phosphorylated proteins on 
M0 primary human macrophages in response to MerTK crosslinking. 
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Next, I assessed the impact of inhibiting PI3K, Syk, and Src-family kinases on MerTK-
induced patterns of protein phosphorylation. Unstimulated or MerTK-crosslinked M0 
macrophages were either left untreated or treated with the PI3K inhibitor LY294002, the 
Syk inhibitor piceatannol, or Src-family kinase inhibitor PP1, and then immunostained 
for phosphoproteins. 
These inhibitors decreased the basal level of phosphorylation in unstimulated cells 
(Figure 12A). As expected, all three inhibitors decreased phosphorylation in response to 
Fcγ receptor activation of protein phosphorylation (Figure 12B). Unexpectedly, 
crosslinking MerTK led to increased tyrosine phosphorylation (Figure 12C) that was 
partially blocked by LY294002 and piceatannol (Figure 12D, E, respectively). PP1 was 
also inhibitory of MerTK-mediated phosphorylation (Figure 12F), consistent with the 
finding from Mero et al.  
69
. Quantification of the mean fluorescence intensity confirmed 
that all three inhibitors induced a statistically significant inhibition of phosphorylation in 
both aggregated human IgG-treated and MerTK crosslinked cells (Figure 12G). Pearson’s 
co-localization analysis showed a similar trend, although PI3K inhibition did not reach 
statistical significance (Figure 12H). These results demonstrate that MerTK tyrosine 
phosphorylation in response to crosslinking is partially dependent on PI3K, Syk and Src-
family kinases. 
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A) 4G10 immunostaining was performed on unstimulated M0 macrophages (top-left), or 
unstimulated M0 macrophages treated with a PI3K inhibitor (LY294002, top-right), Syk 
inhibitor (piceatannol, bottom-left), or Src-family kinase inhibitor (PP1, bottom-right). B) 
4G10 immunostaining was performed on M0 macrophages stimulated with aggregated 
human IgG. Cells were either left untreated or treated with PI3K, Syk or Src-family 
kinase inhibitors.  C) MerTK on untreated M0 macrophages was activated with Cy3-
tagged F(ab’)2 antibody then cells were immunostained for phosphotyrosine. D-F) 
MerTK on D) PI3K-inhibited (LY294002), E) Syk-inhibited (piceatannol) or F) Src-
family kinase-inhibited (PP1) M0 macrophages was crosslinked using a Cy3-tagged 
F(ab’)2 antibody (red) and the cells were immunostained for phosphotyrosine (4G10). G) 
Phosphotyrosine MFI of basal, aggregated human IgG, and MerTK-crosslinked (F(ab’)2) 
cells either left untreated or treated with inhibitors. Data are means + SEM for each 
condition, from two experiments. H) Pearson’s correlation coefficient was measured 
between MerTK and phosphotyrosine on MerTK-crosslinked M0 macrophages that were 
either uninhibited or treated with inhibitors for PI3K, Src-family kinase or Syk. n.s. 
indicate non-statistically significant decrease in co-localization of MerTK with 4G10. 
Asterisks indicate statistically significant changes (P < 0.05) by ANOVA with 
Bonferroni correction. Scale bar is 10 μm. 
 
 
 
 
Figure 12: MerTK tyrosine phosphorylation in response to receptor crosslinking 
is partially dependent on Src/Syk-kinases and PI3K. 
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 Crosslinking MerTK on M0 primary human 3.8
macrophages promotes tyrosine phosphorylation 
Immunoblotting was used to further investigate MerTK-mediated protein 
phosphorylation. Cell lysates from M0 macrophages that were either unstimulated, 
depleted of focal contact phosphorylation by EGTA treatment, treated with aggregated 
human IgG as a positive control, or MerTK-crosslinked, were separated by SDS-PAGE 
and immunoblotted for tyrosine-phosphorylated proteins. Increased tyrosine 
phosphorylation was noted when MerTK was crosslinked (Figure 13), although it was 
much smaller in magnitude and impacted a small number of proteins than did aggregated 
human IgG-induced phosphorylation. Moreover, a phosphoband at approximately 125 
kDa corresponding to MerTK was apparent on the immunoblot (Figure 13, arrow), 
suggestive of MerTK autophosphorylation. This led us to conclude that crosslinking 
MerTK induces phosphorylation of a small subset of downstream proteins. 
 Activation of MerTK on M0 macrophages followed by 3.9
immunoprecipitation of phosphorylated proteins 
Next, I wanted to identify the proteins being phosphorylated in response to MerTK 
crosslinking through immunoprecipitation and mass spectrometry. M0 macrophages were 
either left unstimulated or MerTK was crosslinked, then cell lysates were incubated with 
4G10 (anti-phosphotyrosine) conjugated agarose beads followed by elution of the 
proteins, separation on SDS-PAGE and detection by coomassie staining. Despite several 
attempts and multiple troubleshooting steps, we were unable to recover phosphoproteins 
from these cell lysates (Figure 14). I suspect this failure to recover phosphoproteins was 
likely due to a combination of the low expression of MerTK (relative to other receptors 
such as FcγRIIA), which in turn produced a weak induction protein phosphorylation after 
crosslinking. This was further aggravated by the limited number of macrophages we can 
produce from a single blood preparation. Consequently, we are reattempting the cloning 
of MerTK to create a cell line which expresses higher levels of MerTK, in the hopes that 
such a cell line would produce a higher level of MerTK-dependent phosphorylation and 
thus provide a viable model for the purification of phosphoproteins.
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Phosphotyrosine (4G10) immunoblot of cell lysates from basal, EGTA-treated, 
aggregated human IgG (AgIgG)-treated, and MerTK crosslinked (MerTK x-link) M0 
macrophages. Arrow indicates a phosphoband of the same molecular mass as MerTK. 
Actin was immunoblotted (below) to ensure equal loading. Blot is representative of four 
similar experiments. 
 
 
 
 
 
 
 
 
 
Figure 13: Crosslinking MerTK on M0 primary human macrophages promotes 
tyrosine phosphorylation. 
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Phosphotyrosine immunoprecipitates (pY IP) were prepared from unstimulated (basal) or 
MerTK-crosslinked (MerTK x-link) M0 primary human macrophages. The gel shown is 
representative of six similar experiments. 
Figure 14: Activation of MerTK and immunoprecipitation of tyrosine-
phosphorylated proteins. 
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When successful, this model will be used to identify proteins phosphorylated in response 
to MerTK ligation through immunoprecipitation of the phosphorylated proteins, followed 
by identification by mass spectrometry. 
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Chapter 4: Discussion 
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Chapter 4: Discussion 
 MerTK signalling in efferocytosis 4.1
Efferocytosis is important for the maintenance of cellular homeostasis as it prevents 
autoimmunity and inflammation caused by the release of alarmins and autoantigens from 
uncleared apoptotic cells. MerTK is a major efferocytic receptor and studies have shown 
that MerTK mutations impair efferocytosis, leading to accumulation of apoptotic cells 
and the subsequent pathogenic release of alarmins and autoantigens through secondary 
necrosis 
34,35,41
. The importance of MerTK was first identified in the retina, where MerTK 
is vital for proper clearance of shed photoreceptor outer segments by retinal pigment 
epithelial (RPE) cells. This discovery was made in the RCS rat model which has a 
recessively inherited retinal degeneration caused by a mutation in the MerTK gene 
35,70
. 
Similar mutations are found in individuals with retinitis pigmentosa, further highlighting 
the importance of MerTK in maintenance of the retina 
37
.  
MerTK plays a similarly important role in other tissues, but it should be noted that the 
importance of MerTK relative to other efferocytic receptors varies between tissues.  For 
example, the accumulation of apoptotic cardiomyocytes is not impaired in MerTK 
deficient animals as there are other efferocytic receptors that compensate for the absence 
of MerTK 
71
. However, defective MerTK signalling in mice bone marrow macrophages 
has been shown to promote accumulation of apoptotic cells in models of atherosclerosis, 
leading to inflammation-accelerated atherosclerosis 
42
. For example, in a study by Thorp 
et al. 
43
, in a mouse model of atherosclerosis, MerTK mutation reduced clearance of 
apoptotic cells and promoted necrosis within the atherosclerotic plaque. In other models, 
MerTK has been found to be crucial for prevention of autoimmunity. In particular, 
MerTK mutations and the resulting failure to clear apoptotic cells produces an SLE-like 
disease driven by impaired efferocytosis 
40
. MerTK signalling is critical to prevent this 
pathology, as mice lacking only the intracellular kinase domain of MerTK also develop 
lupus-like autoimmunity 
3
. 
Little is known of MerTK’s signalling pathway; with all signalling discovered to date 
elucidated using the RPE phagocytosis model. Shelby et al. 
26
 evaluated MerTK 
74 
 
 
 
interactions with SH2-domain containing proteins and detected MerTK interactions with 
Grb2, Vav3, PIK3R1, and Src. Src activation was detected downstream of MerTK and 
siRNA knockdown of Grb2 impaired efferocytosis of photoreceptor outer segment. Their 
findings suggest that SH2-domain proteins are integral part of MerTK signalling in RPE, 
but also account for all of what is known of MerTK signalling in the context of 
efferocytosis.  
I hypothesized that MerTK signalling occurs through a pathway unique from that utilized 
by conventional phagocytic receptors such as FcγR and αmβ2. The rational for this 
hypothesis was two-fold, namely 1) other studies have not identified a role for the 
proteins normally involved in these phagocytic pathways downstream of MerTK, and 2) 
MerTK signalling and the resulting efferocytosis is immunologically silent, while 
conventional phagocytosis is pro-inflammatory and immunogenic. Both of these findings 
strongly suggest that MerTK is not signalling through the same signalling pathways used 
by conventional phagocytic receptors. 
 MerTK expression 4.2
MerTK expression had previously been reported in J774.1 murine macrophages 
68
, but 
we were unable to observe consistent MerTK expression in this cell line despite using 
multiple detection techniques and culture conditions. This inconsistency in expression 
suggest that MerTK expression is regulated by unknown cell culture conditions such as 
cell density or the levels of particular cytokines within the fetal bovine serum used to 
prepare the culture media. RAW264.7 and ANA-1 murine macrophages were not found 
to express MerTK, nor could signalling in response to MerTK crosslinking be detected in 
ANA-1 cells (Figure 3E). Other studies have suggested that these murine cell lines are 
constitutively differentiated into an M1 macrophage phenotype 
72
, which our results 
indicate weakly express MerTK (Figure 6). This differentiation may also explain the poor 
MerTK expression in J774.1, RAW264.7 and ANA-1 cells. 
Our failure to identify endogenous MerTK expression in murine cell lines necessitated 
the generation of ectopic MerTK-expressing cells. To date, no other studies have used an 
ectopic expression system of full-length MerTK like the one I attempted to develop. 
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Indeed, I am aware of only open study which used recombinant MerTK, and that study 
only used the intracellular kinase domain of the gene 
71
. The lack of ectopic expression 
tools is probably due to the apparent toxicity of the MerTK gene to the DH5α 
Escherichia coli cells used in all of our cloning approaches. Indeed, we have only ever 
recovered MerTK clones mutated such that the transmembrane/intracellular portions of 
the protein would not be expressed (Figure 4C), consistent with these domains being 
toxic if expressed in E. coli. Consequently, our future work may attempt to clone MerTK 
using yeast cells (eukaryotic cells) as they are more likely to be able to support constructs 
expressing proteins with eukaryotic-specific motifs such as the secretion signals required 
for the proper localization of transmembrane domains 
73
.  
This study then used primary human macrophages as model system for elucidating 
MerTK signalling. Peripheral blood mononuclear cells were differentiated into M0, M1, 
and M2 macrophages through culturing the cells in the presence of specific growth 
factors and environmental stimuli. These differentiation protocols are well-established 
and have been verified by flow cytometry 
74,75
. M0 macrophages were generated by 
culturing with M-CSF and closely resembled the phenotype of macrophages resident in 
healthy tissues. Indeed, M0 macrophages are thought to represent the subtype of 
macrophages involved in tissue homeostasis 
76
. M1 macrophages were generated by 
culturing monocytes with GM-CSF, LPS, and IFN-γ, and are considered to be classically 
activated, pro-inflammatory cells like those found at the sites of bacterial infections 
76,77
. 
M2 macrophages differentiate in the presence of M-CSF plus anti-inflammatory 
cytokines such as IL-4, and are considered to be alternatively activated towards a 
phenotype that suppresses inflammation and promotes cell growth and tissue repair 
76,77
.  
Immunofluorescence analysis was performed on differentiated macrophages to identify 
endogenous MerTK. I hypothesize that MerTK will be present on anti-inflammatory and 
homeostatic (M2 and M0) primary macrophages. As expected, MerTK labelling was 
observed in the M0 and M2 subtypes (Figure 6). M0 cells were used for subsequent 
experiments because these cells are relatively undifferentiated and retain a strong 
capacity for phagocytosis 
76
. My results slightly conflict with the observations of Zizzo et 
al. 
78
, who observed MerTK expression on all subtypes of human macrophages, but with 
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greatly enriched MerTK expression on the anti-inflammatory M2c subtype. This subtype 
of M2 macrophages is formed in the presence of M-CSF and glucocorticoid steroid 
hormones, and represents a cell that is further differentiated compared to the M2 
phenotype induced in my experiments. Indeed, I found MerTK expression on M0 
macrophages as well as M2 macrophages without further differentiation into the M2a/b/c 
subtypes, while contrary to this study, did not observe MerTK on M1 cells. The 
discrepancy is likely attributable to differences in the cell differentiation methods used by 
us versus Zizzo et al. 
78
. Specifically, M-CSF was used in all differentiation media used 
by Zizzo et al. 
78
, while we used M-CSF only in M0 and M2 cultures. This suggests that 
MerTK may be an M-CSF inducible gene – a possibility undergoing further investigation 
in our lab. 
Since different in vitro culture methods lead to differences in MerTK expression in cells 
supposedly differentiated to the same subtype, it will be necessary in the future to assess 
MerTK in macrophages isolated from M0, M1, and M2-like in vivo environments. 
Regardless, the observed expression of MerTK on M0 and M2 macrophages in my study 
(Figure 6) is consistent with these cell types needing to engage in efferocytosis as a 
homeostatic (M0) or tissue remodelling (M2) mechanism. The absence of MerTK on M1 
macrophages (Figure 6) would be consistent with wanting to avoid efferocytosis by cells 
actively involved in inflammation and antigen presentation.  
 Elucidating MerTK signalling 4.3
I first attempted to elucidate MerTK signalling using beads that would selectively engage 
MerTK in a manner that mimics the particulate nature of apoptotic bodies. Challenges 
were encountered while assessing the efferocytic ability of MerTK using this antibody-
coated bead model as I was unable to selectively engage MerTK without co-stimulating 
Fcγ receptors on the macrophages (Figure 7). Such a bead-based model is preferable to 
crosslinking assays as it recapitulates the particulate nature of apoptotic cells. Indeed, 
studies of phagocytosis have demonstrated that while both crosslinking and bead-based 
assay activate the same signalling pathways, the apparent role of these pathways in 
internalization can be different for crosslinked receptors (example, endocytosis) versus 
particulate targets (phagocytosis). For example, PI3K is activated by both crosslinking 
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Fcγ receptors and by IgG-coated beads but is only required for the uptake of IgG-coated 
beads with a diameter greater than 3μm 24,51. Even if these bead-based assays worked, 
they likely would have been incomplete as it may have been difficult to incorporate αvβ5-
specific antibodies or ligands into this bead-based model, making it hard to assess the 
cooperation of MerTK with integrins 
58,79
.Therefore, it is critical in the future that we 
generate a MerTK-specific activation model involving a particulate target that 
incorporates both MerTK-specific and integrin-specific components.  
Apoptotic cells plus exogenously-produced MerTK-specific opsonins were considered, 
but will not suffice as they will express a range of “eat me” signals 9,15, including some 
which can be engaged by receptors such as TIM-4 that are capable of directly binding to 
and internalizing apoptotic cells independently of any opsonins 
22
. Therefore, future 
studies will clone the MerTK-specific opsonin, Gas-6, and the integrin-specific opsonin, 
MFG-E8 (lactadherin) 
14
. Once they are purified, these proteins can be coated onto 
polystyrene beads singularly or together in order to create MerTK-specific, integrin-
specific, or dually-specific efferocytotic targets. This tool would allow us to selectively 
engage MerTK or αvβ5 integrin alone or together, enabling a better differentiation of their 
function in MerTK-mediated efferocytosis and signalling pathways.  
Although we were unable to create a MerTK-specific particulate target, it is well 
established that crosslinking phagocytic receptors induces the same signalling pathways 
as does a particulate target engaging the same receptor 
69
. For example, the efferocytic 
receptor, CD36, has been shown to signal and endocytose upon crosslinking with anti-
CD36 IgA and a secondary F(ab’)2 antibody using the same pathways required for CD36-
mediated phagocytosis of pathogens, and uptake of other particulates such as oxidized 
LDL 
19
. Similarly, we were able to induce endocytosis by crosslinking MerTK with a 
F(ab’)2. F(ab’)2 was used to avoid stimulating Fcγ receptors present on macrophages, 
which specifically recognize the Fc region of antibodies that is removed during 
preparation of F(ab’)2 fragments 
19
. Using this model, we assessed the role of Src-family 
kinases, Syk, and PI3K on MerTK-mediated endocytosis and phosphotyrosine signalling 
(Figures 9, 12).   
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Our studies identified a significant decrease in MerTK-induced protein phosphorylation 
when PI3K activity was inhibited (Figure 12D). Despite this, PI3K inhibition had no 
impact on the endocytosis of crosslinked MerTK (Figure 9C). This is consistent with the 
observations of Cox et al. 
51
, who determined that Fcγ receptor-mediated phagocytosis 
required PI3K-induced actin polymerization. They found that the PI3K inhibitors, 
LY294002 and wortmannin, prevented Fcγ receptor-mediated phagocytosis and 
pseudopod extension. Importantly, LY294002 and wortmannin only inhibited the 
phagocytosis of particles greater than 3μm suggesting that PI3K is necessary for 
engulfment of particles greater than 3μm but not smaller ones 51. This size-dependent 
effect may explain the lack of PI3K involvement in MerTK endocytosis, as the MerTK-
induced PI3K activity may only be required for internalization of particulate targets.  
Much to our surprise Src-family kinase/Syk inhibition had no impact on MerTK 
endocytosis (Figure 9E and 9D, respectively). This was surprising as inhibition of these 
proteins typically blocks internalization through most phagocytic receptors independent 
of particle size, including in assays of antibody-mediated receptor crosslinking 
19,58,80
. 
Oddly, Src-family kinase and Syk inhibition reduced total phosphorylation induced by 
MerTK crosslinking (Figure 12F and 12E, respectively) suggesting that while MerTK 
was activating the Src-family kinase/Syk kinase pathway, a novel Src-family kinase/Syk 
independent pathway was being used to mediate MerTK internalization. Given these 
results, I predict that future studies using a MerTK-specific bead-based assay will 
identify a role of PI3K for engulfment of MerTK-specific particles greater than 3μm in 
diameter, while Src-family kinase/Syk will not be involved in the uptake of these 
particulate targets.  
The signalling patterns of MerTK varied from that used by Fcγ receptors in more than the 
requirement for Src/Syk-family kinases. Indeed, both immunofluorescence and 
immunoblotting revealed that MerTK had a much smaller impact on the change in 
protein phosphorylation than did Fcγ receptor signalling (Figures 11B, 11C, and Figure 
13). Immunoblotting confirmed that MerTK activation led to phosphorylation of a 
smaller number of proteins than did aggregated IgG (Figure 13), and moreover, increased 
phosphorylation was observed only proximal to MerTK without significant changes 
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observed at the whole cell level (Figure 11C and 11E). This suggests that MerTK is 
phosphorylating only a small portion of proximal proteins, without the cell-wide changes 
in phosphorylation patterns observed downstream of Fcγ receptor engagement. I 
attempted to identify these MerTK-phosphorylated proteins using a phosphotyrosine 
immunoprecipitation (Figure 14), but the low level of protein phosphorylation induced by 
endogenous MerTK stymied this experiment. Therefore, in the future we aim to generate 
cells ectopically expressing MerTK at a high level, allowing for an induction of MerTK-
dependent phosphorylation that is sufficient for phosphotyrosine immunoprecipitation. 
 Implications of MerTK signalling in health and disease 4.4
It is evident that MerTK plays an important role in efferocytosis and homeostasis as 
MerTK mutations are associated with the accumulation of apoptotic cells, development 
of lupus-like autoimmunity, and worsening of inflammatory diseases such as 
atherosclerosis 
3,42,43,71
. We have discovered that MerTK is expressed in M0 and M2 
macrophage subtypes (Figure 6), which is expected as these cell types are known to play 
a homeostatic role in clearing apoptotic cells and tissue remodelling after injury 
81
. These 
findings are interesting in the context of atherosclerosis, as it is well established that M1 
cells are common in the atherosclerotic plaque, suggesting that inappropriate 
differentiation of macrophages to an M1 phenotype within the vascular intima may be a 
critical step in the development of an atheroma 
78,81,82
.  
We have also discovered that MerTK is internalized upon activation through a pathway 
independent of the common regulators of phagocytosis. Interestingly, a portion of the 
MerTK signalling is dependent on these signalling molecules, even though the 
internalization of MerTK is not. Although further elucidation of MerTK signalling 
pathway is required to better understand what is occurring, these findings suggest that 
anti-inflammatory or anti-autoimmune therapies targeting the Src/Syk pathway should 
not impair efferocytosis through MerTK. Such therapies may be of great benefit, given 
the central role of Src-family kinase and Syk in mediating inflammatory processes 
83
. 
Indeed, there is strong evidence linking Src-family kinases to acute inflammatory 
signalling, with animal studies demonstrating that inhibitors of Src-family kinases reduce 
acute inflammation and tissue injury 
83–85
.  
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Our data also has implication in autoimmune disease. Previous studies have shown that 
knockout mice lacking MerTK or its opsonins develop autoimmune disease, suggestive 
that any defect in MerTK signalling may result in autoimmunity 
3
. Indeed, we hope that 
our continued study of MerTK signalling may identify critical signalling pathways which 
become impaired during the induction of autoimmunity. Identification of these pathways 
may lead to pharmacological targets for prevention or treatment of autoimmune disease. 
One such pathway may be the Src/Syk pathway assessed in this thesis. Indeed, we 
observed that MerTK induced phosphorylation via Src-family kinase and Syk, but that 
MerTK internalization was independent of these kinases. If this observation holds true, 
this may offer to opportunity to inhibit autoimmune responses by blocking components of 
the Src-family kinase/Syk signalling pathway without blocking efferocytosis. This would 
therefore allow us to block Src-family kinase signalling, which is previously established 
to be associated with autoimmunity 
86
, without reducing the clearance of apoptotic cells 
and thus avoiding further complications due to poor apoptotic cell clearance.  
PI3K is also linked with inflammation and autoimmunity, for instance Barber et al. 
87
 and 
Camps et al. 
88
 discovered inhibitors that blocked PI3Kγ complex, reduced 
glomerulonephritis, lupus, and rheumatoid arthritis in mouse models. However, PI3K is 
not as viable a target as it may be required for the uptake of particulate targets, and 
therefore PI3K inhibition may block some aspects of autoimmunity while at the same 
time augment autoantigen and alarmin release through reducing efferocytosis.  
Lastly, because MerTK is internalized independently of the commonly used Src/Syk 
pathway, full elucidation of the MerTK signalling pathway will require an undirected 
approach such as the immunoprecipitation of tyrosine-phosphorylated proteins attempted 
in my final objective (Figure 14). Such an assay would allow for identification of the 
pathways lying downstream of MerTK activation, with follow-up assays such as siRNA 
knockdown of the identified signalling molecules used to assess the role of the proteins in 
MerTK-mediated efferocytosis. The significance of these future studies is that they will 
provide insights into MerTK’s function under homeostatic conditions, and ultimately 
provide the knowledge necessary to understand how MerTK is dysfunctional under 
inflammatory (example, atherosclerotic) or autoimmune conditions. This research has the 
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potential to identify novel therapeutic and preventative strategies for inflammatory and 
autoimmune diseases through reversing defects in MerTK function or otherwise altering 
MerTK-dependent signalling. 
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Appendix 
 
 
 
 
 
 
 
Figure A1: Plasmid maps of source and attempted MerTk mammalian expression 
vectors. A-B) – source vectors for murine (A) pIRES2-EGFP MerTK from Addgene, and 
human (B) pDONR233-MerTK from Addgene. C-E) attempted MerTK expression 
vectors: C) Wild-type murine MerTK, D) GFP murine MerTK and E) wild-type human 
MerTK. Plasmid maps A-B are from Addgene, all others were created with SnapGene 
software.
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